<html class="gs_el_sm gs_pfcs"><head><title>‪Christopher McGuigan‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=uaahAI4m4mMC&amp;hl=en"><meta name="description" content="‪(1958 - 2016) Professor, Welsh School of Pharmacy, Cardiff University‬ - ‪‪Cited by 9,933‬‬ - ‪medicinal chemistry‬ - ‪drug discovery‬ - ‪antivirals‬ - ‪anticancer‬ - ‪nucleosides‬"><meta property="og:description" content="‪(1958 - 2016) Professor, Welsh School of Pharmacy, Cardiff University‬ - ‪‪Cited by 9,933‬‬ - ‪medicinal chemistry‬ - ‪drug discovery‬ - ‪antivirals‬ - ‪anticancer‬ - ‪nucleosides‬"><meta property="og:title" content="Christopher McGuigan"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=uaahAI4m4mMC&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"3og9YaD5DYnwmgGHsJCwCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=uaahAI4m4mMC" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT7aXq_nRtBaaRJY8dqUubF7jMO6sjVA"><input type="hidden" name="user" value="uaahAI4m4mMC"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">9933</td><td class="gsc_rsb_std">3203</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">53</td><td class="gsc_rsb_std">28</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">181</td><td class="gsc_rsb_std">95</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1090px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1048px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">660</div><div class="gsc_g_xtl" style="top:73px;">330</div><div class="gsc_g_xtl" style="top:113px;">165</div><div class="gsc_g_xtl" style="top:33px;">495</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:154px;height:6px;z-index:32"><span class="gsc_g_al">25</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:151px;height:9px;z-index:31"><span class="gsc_g_al">40</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:146px;height:14px;z-index:30"><span class="gsc_g_al">59</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:144px;height:16px;z-index:29"><span class="gsc_g_al">69</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:140px;height:20px;z-index:28"><span class="gsc_g_al">86</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:142px;height:18px;z-index:27"><span class="gsc_g_al">77</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:125px;height:35px;z-index:26"><span class="gsc_g_al">145</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:145px;height:15px;z-index:25"><span class="gsc_g_al">65</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:128px;height:32px;z-index:24"><span class="gsc_g_al">135</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:132px;height:28px;z-index:23"><span class="gsc_g_al">119</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:124px;height:36px;z-index:22"><span class="gsc_g_al">149</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:125px;height:35px;z-index:21"><span class="gsc_g_al">147</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:104px;height:56px;z-index:20"><span class="gsc_g_al">234</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:85px;height:75px;z-index:19"><span class="gsc_g_al">312</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:90px;height:70px;z-index:18"><span class="gsc_g_al">292</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:80px;height:80px;z-index:17"><span class="gsc_g_al">331</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:86px;height:74px;z-index:16"><span class="gsc_g_al">307</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:81px;height:79px;z-index:15"><span class="gsc_g_al">326</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:102px;height:58px;z-index:14"><span class="gsc_g_al">243</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:38px;height:122px;z-index:13"><span class="gsc_g_al">505</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:76px;height:84px;z-index:12"><span class="gsc_g_al">347</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:61px;height:99px;z-index:11"><span class="gsc_g_al">412</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:68px;height:92px;z-index:10"><span class="gsc_g_al">380</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:23px;height:137px;z-index:9"><span class="gsc_g_al">568</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:8px;height:152px;z-index:8"><span class="gsc_g_al">627</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:0px;height:160px;z-index:7"><span class="gsc_g_al">660</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:32px;height:128px;z-index:6"><span class="gsc_g_al">532</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:12px;height:148px;z-index:5"><span class="gsc_g_al">613</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:25px;height:135px;z-index:4"><span class="gsc_g_al">559</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:30px;height:130px;z-index:3"><span class="gsc_g_al">537</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:22px;height:138px;z-index:2"><span class="gsc_g_al">572</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:67px;height:93px;z-index:1"><span class="gsc_g_al">386</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=uaahAI4m4mMC" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3duaahAI4m4mMC'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>16 articles</span></div><div class="gsc_rsb_m_na"><div>3 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:16%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:107px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:66pt;height:80pt;}}</style><img alt="Christopher McGuigan" sizes="print 66px,107px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=uaahAI4m4mMC&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=uaahAI4m4mMC&amp;citpid=1 107w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=uaahAI4m4mMC&amp;citpid=1 214w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Christopher McGuigan</div><div class="gsc_prf_il">(1958 - 2016) Professor, Welsh School of Pharmacy, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=9175319048828668389" class="gsc_prf_ila">Cardiff University</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at cardiff.ac.uk - <a href="http://www.cardiff.ac.uk/obituaries/obituary/professor-chris-mcguigan" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:medicinal_chemistry" class="gsc_prf_inta gs_ibl">medicinal chemistry</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:drug_discovery" class="gsc_prf_inta gs_ibl">drug discovery</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:antivirals" class="gsc_prf_inta gs_ibl">antivirals</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:anticancer" class="gsc_prf_inta gs_ibl">anticancer</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:nucleosides" class="gsc_prf_inta gs_ibl">nucleosides</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT7aXq_nRtBaaRJY8dqUubF7jMO6sjVA"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=uaahAI4m4mMC&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:HDshCWvjkbEC" class="gsc_a_at">Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT</a><div class="gs_gray">C McGuigan, RN Pathirana, J Balzarini, E De Clercq</div><div class="gs_gray">Journal of medicinal chemistry 36 (8), 1048-1052<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7629236534931985409" class="gsc_a_ac gs_ibl">306</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:mB3voiENLucC" class="gsc_a_at">Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite</a><div class="gs_gray">C McGuigan, D Cahard, HM Sheeka, E De Clercq, J Balzarini</div><div class="gs_gray">Journal of medicinal chemistry 39 (8), 1748-1753<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18269441460611990787" class="gsc_a_ac gs_ibl">297</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:TQgYirikUcIC" class="gsc_a_at">Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base</a><div class="gs_gray">C McGuigan, CJ Yarnold, G Jones, S Velázquez, H Barucki, A Brancale, ...</div><div class="gs_gray">Journal of medicinal chemistry 42 (22), 4479-4484<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17777435616229200853" class="gsc_a_ac gs_ibl">242</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:iH-uZ7U-co4C" class="gsc_a_at">Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications</a><div class="gs_gray">PC Trippier, C McGuigan</div><div class="gs_gray">MedChemComm 1 (3), 183-198<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=324395588587678485" class="gsc_a_ac gs_ibl">237</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:R3hNpaxXUhUC" class="gsc_a_at">Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain</a><div class="gs_gray">C McGuigan, H Barucki, S Blewett, A Carangio, JT Erichsen, G Andrei, ...</div><div class="gs_gray">Journal of medicinal chemistry 43 (26), 4993-4997<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10768885078723084301" class="gsc_a_ac gs_ibl">222</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:4JMBOYKVnBMC" class="gsc_a_at">Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells</a><div class="gs_gray">Y Mehellou, J Balzarini, C McGuigan</div><div class="gs_gray">ChemMedChem: Chemistry Enabling Drug Discovery 4 (11), 1779-1791<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13712317911152703660" class="gsc_a_ac gs_ibl">218</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:e5wmG9Sq2KIC" class="gsc_a_at">Aryloxy phosphoramidate triesters as pro-tides.</a><div class="gs_gray">D Cahard, C McGuigan, J Balzarini</div><div class="gs_gray">Mini reviews in medicinal chemistry 4 (4), 371-381<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7752785996064263740" class="gsc_a_ac gs_ibl">214</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:RHpTSmoSYBkC" class="gsc_a_at">Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT</a><div class="gs_gray">C McGuigan, RN Pathirana, N Mahmood, KG Devine, AJ Hay</div><div class="gs_gray">Antiviral research 17 (4), 311-321<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8538902197417388275" class="gsc_a_ac gs_ibl">183</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:u5HHmVD_uO8C" class="gsc_a_at">Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives</a><div class="gs_gray">J Balzarini, A Karlsson, S Aquaro, CF Perno, D Cahard, L Naesens, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 93 (14), 7295-7299<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15702018948380354619" class="gsc_a_ac gs_ibl">176</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:_Qo2XoVZTnwC" class="gsc_a_at">Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine</a><div class="gs_gray">D Saboulard, L Naesens, D Cahard, A Salgado, R Pathirana, ...</div><div class="gs_gray">Molecular Pharmacology 56 (4), 693-704<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11843759976650425306" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:j3f4tGmQtD8C" class="gsc_a_at">The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: a structure− activity relationship</a><div class="gs_gray">AQ Siddiqui, C Ballatore, C McGuigan, E De Clercq, J Balzarini</div><div class="gs_gray">Journal of medicinal chemistry 42 (3), 393-399<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3443545441736283887" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:HoB7MX3m0LUC" class="gsc_a_at">Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development</a><div class="gs_gray">M Slusarczyk, MH Lopez, J Balzarini, M Mason, WG Jiang, S Blagden, ...</div><div class="gs_gray">Journal of medicinal chemistry 57 (4), 1531-1542<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10463052343355201392" class="gsc_a_ac gs_ibl">141</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:r0BpntZqJG4C" class="gsc_a_at">Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues</a><div class="gs_gray">A Lisco, C Vanpouille, EP Tchesnokov, JC Grivel, A Biancotto, ...</div><div class="gs_gray">Cell host &amp; microbe 4 (3), 260-270<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=445149100083361317" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:sSrBHYA8nusC" class="gsc_a_at">Phosphoramidate compounds and methods of use</a><div class="gs_gray">C McGuigan</div><div class="gs_gray">US Patent 7,951,787<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11301848564371991709" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:geHnlv5EZngC" class="gsc_a_at">Antiviral phosphoramidates</a><div class="gs_gray">K Klumpp, JA Martin, C McGuigan, DB Smith</div><div class="gs_gray">US Patent 7,608,599<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14026328208265968042" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:YFjsv_pBGBYC" class="gsc_a_at">Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus</a><div class="gs_gray">C McGuigan, K Madela, M Aljarah, A Gilles, A Brancale, N Zonta, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 20 (16), 4850-4854<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11296295597007857788" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:k_IJM867U9cC" class="gsc_a_at">Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication</a><div class="gs_gray">J Balzarini, C McGuigan</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 50 (1), 5-9<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10414043188306827981" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:maZDTaKrznsC" class="gsc_a_at">Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency</a><div class="gs_gray">C McGuigan, SA Harris, SM Daluge, KS Gudmundsson, EW McLean, ...</div><div class="gs_gray">Journal of medicinal chemistry 48 (10), 3504-3515<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12414320332415077362" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:rO6llkc54NcC" class="gsc_a_at">Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy</a><div class="gs_gray">F Pertusat, M Serpi, C McGuigan</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 22 (5), 181-203<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13855753043086194609" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;citation_for_view=uaahAI4m4mMC:bEWYMUwI8FkC" class="gsc_a_at">Application of the phosphoramidate ProTide approach to 4 ‘-azidouridine confers sub-micromolar potency versus Hepatitis C virus on an Inactive Nucleoside</a><div class="gs_gray">P Perrone, GM Luoni, MR Kelleher, F Daverio, A Angell, S Mulready, ...</div><div class="gs_gray">Journal of medicinal chemistry 50 (8), 1840-1849<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8032102326650378896" class="gsc_a_ac gs_ibl">113</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:TFP_iSt0sucC" class="gsc_a_at">Synthesis and biological properties of some cyclic phosphotriesters derived from 2'-deoxy-5-fluorouridine</a><div class="gs_gray">RN Hunston, AS Jones, C McGuigan, RT Walker, J Balzarini, E De Clercq</div><div class="gs_gray">Journal of medicinal chemistry 27 (4), 440-444<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7229573629478274200" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:hMod-77fHWUC" class="gsc_a_at">Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA</a><div class="gs_gray">C Ballatore, C McGuigan, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 11 (8), 1053-1056<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6078566322469135077" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:NaGl4SEjCO4C" class="gsc_a_at">The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition</a><div class="gs_gray">M Derudas, D Carta, A Brancale, C Vanpouille, A Lisco, L Margolis, ...</div><div class="gs_gray">Journal of medicinal chemistry 52 (17), 5520-5530<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18378534029059551672" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:2P1L_qKh6hAC" class="gsc_a_at">Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside</a><div class="gs_gray">C McGuigan, P Murziani, M Slusarczyk, B Gonczy, J Vande Voorde, ...</div><div class="gs_gray">Journal of medicinal chemistry 54 (20), 7247-7258<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5918639359586281746" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:CaZNVDsoPx4C" class="gsc_a_at">Chemical compounds</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 6,455,513<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14034253436562017744" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:M3NEmzRMIkIC" class="gsc_a_at">Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variation</a><div class="gs_gray">C McGuigan, HW Tsang, D Cahard, K Turner, S Velazquez, A Salgado, ...</div><div class="gs_gray">Antiviral research 35 (3), 195-204<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4401214075942790496" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:JV2RwH3_ST0C" class="gsc_a_at">Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR</a><div class="gs_gray">AQ Siddiqui, C McGuigan, C Ballatore, F Zuccotto, IH Gilbert, E De Clercq, ...</div><div class="gs_gray">Journal of medicinal chemistry 42 (20), 4122-4128<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6901841279126143218" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:isC4tDSrTZIC" class="gsc_a_at">Conversion of 2′, 3′-dideoxyadenosine (ddA) and 2′, 3′-didehydro-2′, 3′-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly&nbsp;…</a><div class="gs_gray">J Balzarini, J Kruining, O Wedgwood, C Pannecouque, S Aquaro, ...</div><div class="gs_gray">FEBS letters 410 (2-3), 324-328<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11199930697157840799" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:SeFeTyx0c_EC" class="gsc_a_at">Compounds useful as A3 adenosine receptor agonists</a><div class="gs_gray">LG Sevillano, C McGuigan, RH Davies</div><div class="gs_gray">US Patent 7,414,036<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5232761142792371062" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:GnPB-g6toBAC" class="gsc_a_at">Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus</a><div class="gs_gray">C McGuigan, RN Pathirana, M Migliore, R Adak, G Luoni, AT Jones, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 60 (6), 1316-1330<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17311650300375647076" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:NMxIlDl6LWMC" class="gsc_a_at">Anti-HIV and anti-HBV activity and resistance profile of 2′, 3′-dideoxy-3′-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109</a><div class="gs_gray">J Balzarini, O Wedgwood, J Kruining, H Pelemans, R Heijtink, ...</div><div class="gs_gray">Biochemical and biophysical research communications 225 (2), 363-369<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18274539281758988751" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:blknAaTinKkC" class="gsc_a_at">Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells</a><div class="gs_gray">C McGuigan, D Cahard, HM Sheeka, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 6 (10), 1183-1186<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17669053362666759012" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:ns9cj8rnVeAC" class="gsc_a_at">First example of phosphoramidate approach applied to a 4 ‘-substituted purine nucleoside (4 ‘-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound&nbsp;…</a><div class="gs_gray">P Perrone, F Daverio, R Valente, S Rajyaguru, JA Martin, V Lévêque, ...</div><div class="gs_gray">Journal of medicinal chemistry 50 (22), 5463-5470<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15750271953191692707" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:O3NaXMp0MMsC" class="gsc_a_at">Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound</a><div class="gs_gray">C McGuigan, KG Devine, TJ O'Connor, D Kinchington</div><div class="gs_gray">Antiviral research 15 (3), 255-263<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1448218517053649207" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:RoXSNcbkSzsC" class="gsc_a_at">Synthesis and evaluation of some novel phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT) as anti-HIV compounds</a><div class="gs_gray">C McGuigan, KG Devine, TJ O'Connor, SA Galpin, DJ Jeffries, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 1 (2), 107-113<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10039719045485286183" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:J_g5lzvAfSwC" class="gsc_a_at">Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin</a><div class="gs_gray">C McGuigan, JC Thiery, F Daverio, WG Jiang, G Davies, M Mason</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 13 (9), 3219-3227<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7810301848517532939" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:cK4Rrx0J3m0C" class="gsc_a_at">Chemical compounds</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 7,018,989<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10921691575382644820" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:BqipwSGYUEgC" class="gsc_a_at">Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic&nbsp;…</a><div class="gs_gray">C McGuigan, RN Pathirana, R Snoeck, G Andrei, E De Clercq, J Balzarini</div><div class="gs_gray">Journal of medicinal chemistry 47 (7), 1847-1851<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4407573401000256879" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:lSLTfruPkqcC" class="gsc_a_at">INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent&nbsp;…</a><div class="gs_gray">JH Vernachio, B Bleiman, KD Bryant, S Chamberlain, D Hunley, ...</div><div class="gs_gray">Antimicrobial agents and chemotherapy 55 (5), 1843-1851<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4039669857920895172" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:d1gkVwhDpl0C" class="gsc_a_at">Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides</a><div class="gs_gray">G Andrei, R Sienaert, C McGuigan, ED Clercq, J Balzarini, R Snoeck</div><div class="gs_gray">Antimicrobial agents and chemotherapy 49 (3), 1081-1086<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8807984658071558897" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:ZHo1McVdvXMC" class="gsc_a_at">Phosphoramidate ProTides of 2′-<i>C</i>-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties</a><div class="gs_gray">C McGuigan, A Gilles, K Madela, M Aljarah, S Holl, S Jones, J Vernachio, ...</div><div class="gs_gray">Journal of medicinal chemistry 53 (13), 4949-4957<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10124063990173834990" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:u-x6o8ySG0sC" class="gsc_a_at">Antiretrovirus specificity and intracellular metabolism of 2', 3'-didehydro-2', 3'-dideoxythymidine (stavudine) and its 5'-monophosphate triester prodrug So324.</a><div class="gs_gray">J Balzarini, H Egberink, K Hartmann, D Cahard, T Vahlenkamp, ...</div><div class="gs_gray">Molecular Pharmacology 50 (5), 1207-1213<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14013007539882622243" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:RGFaLdJalmkC" class="gsc_a_at">Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides</a><div class="gs_gray">J Balzarini, C McGuigan</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2483486329360383374" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:WqliGbK-hY8C" class="gsc_a_at">Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus</a><div class="gs_gray">C McGuigan, P Perrone, J Neyts</div><div class="gs_gray">US Patent 8,658,616<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8238033741315712536" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:35N4QoGY0k4C" class="gsc_a_at">Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA</a><div class="gs_gray">C McGuigan, SM Tollerfield, PA Riley</div><div class="gs_gray">Nucleic acids research 17 (15), 6065-6075<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9573327493222205267" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:4OULZ7Gr8RgC" class="gsc_a_at">Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives</a><div class="gs_gray">C McGuigan, A Hassan-Abdallah, S Srinivasan, Y Wang, A Siddiqui, ...</div><div class="gs_gray">Journal of medicinal chemistry 49 (24), 7215-7226<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18445016005050427235" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:vV6vV6tmYwMC" class="gsc_a_at">Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded&nbsp;…</a><div class="gs_gray">R Sienaert, L Naesens, A Brancale, E De Clercq, C McGuigan, J Balzarini</div><div class="gs_gray">Molecular pharmacology 61 (2), 249-254<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17666382945330877179" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:WbkHhVStYXYC" class="gsc_a_at">Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents</a><div class="gs_gray">C McGuigan, K Madela, M Aljarah, C Bourdin, M Arrica, E Barrett, S Jones, ...</div><div class="gs_gray">Journal of medicinal chemistry 54 (24), 8632-8645<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18181523696808246230" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:D03iK_w7-QYC" class="gsc_a_at">The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4′-azidocytidine (R1479)</a><div class="gs_gray">C McGuigan, MR Kelleher, P Perrone, S Mulready, G Luoni, F Daverio, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 19 (15), 4250-4254<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15734487748911078508" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:ldfaerwXgEUC" class="gsc_a_at">Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T)</a><div class="gs_gray">C McGuigan, PW Sutton, D Cahard, K Turner, G O'Leary, Y Wang, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 9 (6), 473-479<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4091633379631850691" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:M05iB0D1s5AC" class="gsc_a_at">Synthesis and anti-HIV activity of some novel chain-extended phosphoramidate derivatives of d4T (stavudine): esterase hydrolysis as a rapid predictive test for antiviral potency</a><div class="gs_gray">C McGuigan, HW Tsang, PW Sutton, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 9 (2), 109-115<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6969541019792207825" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:70eg2SAEIzsC" class="gsc_a_at">Phosphoramidate derivatives of 2′, 3′-didehydro-2′, 3′-dideoxyadenosine [d4A] have markedly improved anti-HIV potency and selectivity</a><div class="gs_gray">C McGuigan, OM Wedgwood, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 6 (19), 2359-2362<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9868699105838397769" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:uVUOdF_882EC" class="gsc_a_at">Synthesis of some novel dialkyl phosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs</a><div class="gs_gray">C McGuigan, SR Nicholls, TJ O'Connor, D Kinchington</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 1 (1), 25-33<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18181120261047106840" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:RYcK_YlVTxYC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): the effect of a terminal halogen substitution in the side-chain</a><div class="gs_gray">A Brancale, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 10 (11), 1215-1217<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16041051246850708235" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:PELIpwtuRlgC" class="gsc_a_at">Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections</a><div class="gs_gray">S Chamberlain, J Hutchins, K Madela, C McGuigan, J Vernachio, ...</div><div class="gs_gray">US Patent 8,759,318<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9368368348347013939" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:u_35RYKgDlwC" class="gsc_a_at">Novel potential anticancer naphthyl phosphoramidates of BVdU: separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center</a><div class="gs_gray">C Congiatu, A Brancale, MD Mason, WG Jiang, C McGuigan</div><div class="gs_gray">Journal of medicinal chemistry 49 (2), 452-455<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11299831007385366474" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:3s1wT3WcHBgC" class="gsc_a_at">Kinase bypass: a new strategy for anti-HIV drug design</a><div class="gs_gray">C McGuigan, D Kinchington, SR Nicholls, C Nickson, TJ O'Connor</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 3 (6), 1207-1210<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17242499583733555106" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:mKu_rENv82IC" class="gsc_a_at">Novel phosphate derivatives of zidovudine as anti-HIV compounds</a><div class="gs_gray">KG Devine, C McGuigan, TJ O'Connor, SR Nicholls, D Kinchington</div><div class="gs_gray">AIDS (London, England) 4 (4), 371-373<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9459212572358523377" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:zA6iFVUQeVQC" class="gsc_a_at">Molecular similarity of anti-HIV phospholipids</a><div class="gs_gray">DL Cooper, KA Mort, NL Allan, D Kinchington, C McGuigan</div><div class="gs_gray">Journal of the American Chemical Society 115 (26), 12615-12616<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3434867224821991807" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:p2g8aNsByqUC" class="gsc_a_at">Quantitative assays for esterified oxylipins generated by immune cells</a><div class="gs_gray">AH Morgan, VJ Hammond, L Morgan, CP Thomas, KA Tallman, ...</div><div class="gs_gray">Nature protocols 5 (12), 1919-1931<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17667445487022032011" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:O0nohqN1r9EC" class="gsc_a_at">Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd</a><div class="gs_gray">C McGuigan, TJ O'Connor, SR Nicholls, C Nickson, D Kinchington</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 1 (6), 355-360<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17455796169960392683" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:cFHS6HbyZ2cC" class="gsc_a_at">Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity</a><div class="gs_gray">D Curley, C McGuigan, KG Devine, TJ O'Connor, DJ Jeffries, ...</div><div class="gs_gray">Antiviral research 14 (6), 345-356<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12438754528395957242" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:pqnbT2bcN3wC" class="gsc_a_at">Separation of individual antiviral nucleotide prodrugs from synthetic mixtures using cross-reactivity of a molecularly imprinted stationary phase</a><div class="gs_gray">CJ Allender, KR Brain, C Ballatore, D Cahard, A Siddiqui, C McGuigan</div><div class="gs_gray">Analytica chimica acta 435 (1), 107-113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12876948229298230767" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:SP6oXDckpogC" class="gsc_a_at"><i>In Vitro</i>-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype&nbsp;…</a><div class="gs_gray">G Andrei, D Topalis, P Fiten, C McGuigan, J Balzarini, G Opdenakker, ...</div><div class="gs_gray">Journal of virology 86 (5), 2641-2652<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13719056612471996647,7529261408792664616" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:dfsIfKJdRG4C" class="gsc_a_at">Furano pyrimidines as novel potent and selective anti-VZV agents</a><div class="gs_gray">C McGuigan, A Brancale, H Barucki, S Srinivasan, G Jones, R Pathirana, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 12 (2), 77-89<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=889010366478869839" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:fPk4N6BV_jEC" class="gsc_a_at">The phosphoramidate ProTide approach greatly enhances the activity of β-2′-C-methylguanosine against hepatitis C virus</a><div class="gs_gray">C McGuigan, P Perrone, K Madela, J Neyts</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 19 (15), 4316-4320<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14398142488595177049" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:g5m5HwL7SMYC" class="gsc_a_at">Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles</a><div class="gs_gray">C McGuigan, A Brancale, H Barucki, S Srinivasan, G Jones, R Pathirana, ...</div><div class="gs_gray">Drugs of the Future 25 (11), 1151-1161<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3578252412980286778" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:1sJd4Hv_s6UC" class="gsc_a_at">Aryl phosphate derivates of AZT inhibit HIV replication in cells where the nucleoside is poorly active</a><div class="gs_gray">C McGuigan, RN Pathirana, N Mahmood, AJ Hay</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 2 (7), 701-704<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10428129085917908630" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:qjMakFHDy7sC" class="gsc_a_at">Topical delivery of retinyl ascorbate co-drug</a><div class="gs_gray">K Abdulmajed, CM Heard, C McGuigan, WJ Pugh</div><div class="gs_gray">Skin pharmacology and physiology 17 (6), 274-282<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5188601343221619076,5199215617697765123" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:EUQCXRtRnyEC" class="gsc_a_at">Synthesis and Antiviral Evaluation of Phosphoramidate Derivatives of (<i>E</i>)-5-(2-Bromovinyl)-2′-Deoxyuridine</a><div class="gs_gray">SA Harris, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 12 (5), 293-300<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9621919850343440366" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:Fu2w8maKXqMC" class="gsc_a_at">Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer</a><div class="gs_gray">M Bassetto, S Ferla, F Pertusati, S Kandil, AD Westwell, A Brancale, ...</div><div class="gs_gray">European journal of medicinal chemistry 118, 230-243<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6862862157561802035" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:pyW8ca7W8N0C" class="gsc_a_at">Aryl furano pyrimidines: the most potent and selective anti-VZV agents reported to date</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">Antiviral research 71 (2-3), 149-153<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9422573146013584478" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:eJXPG6dFmWUC" class="gsc_a_at">Dual pro-drugs of 2′-<i>C</i>-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus</a><div class="gs_gray">C McGuigan, K Madela, M Aljarah, A Gilles, SK Battina, CVS Ramamurty, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 21 (19), 6007-6012<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7617406610264483188" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:9yKSN-GCB0IC" class="gsc_a_at">Phosphoramidates as potent prodrugs of anti-HIV nucleotides: studies in the amino region</a><div class="gs_gray">C McGuigan, D Cahard, A Salgado, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 7 (1), 31-36<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11111700205383781857" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:yD5IFk8b50cC" class="gsc_a_at">Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by‐pass thymidine kinase</a><div class="gs_gray">C McGuigan, P Bellevergue, H Sheeka, N Mahmood, AJ Hay</div><div class="gs_gray">FEBS letters 351 (1), 11-14<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1996194730086308638" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:1DsIQWDZLl8C" class="gsc_a_at">Synthesis and anti-HIV activity of some novel phosphorodiamidate derivatives of 3′-azido-3′-deoxythymidine (AZT)</a><div class="gs_gray">B Jones, C McGuigan, TJ O'Connor, DJ Jeffries, D Kinchington</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 2 (1), 35-39<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11341155950635143510" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:olpn-zPbct0C" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 7,820,631<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9335814417147538604,18087127844533662403" class="gsc_a_ac gs_ibl">40</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="uaahAI4m4mMC:olpn-zPbct0C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:ce2CqMG-AY4C" class="gsc_a_at">Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities</a><div class="gs_gray">YP Li, GZ Shan, ZG Peng, JH Zhu, S Meng, T Zhang, LY Gao, PZ Tao, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 20 (6), 259-268<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16263157061626175840" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:738O_yMBCRsC" class="gsc_a_at">Phosphoramidates of 2′-β-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism</a><div class="gs_gray">Y Mehellou, R Valente, H Mottram, E Walsby, KI Mills, J Balzarini, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 18 (7), 2439-2446<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4443209802992347519" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:OU6Ihb5iCvQC" class="gsc_a_at">Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin</a><div class="gs_gray">M Derudas, A Brancale, L Naesens, J Neyts, J Balzarini, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 18 (7), 2748-2755<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16810468438079038894" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:_xSYboBqXhAC" class="gsc_a_at">Bicyclic anti-VZV nucleosides: <i>Thieno</i> analogues retain full antiviral activity</a><div class="gs_gray">A Brancale, C McGuigan, B Algain, P Savy, R Benhida, JL Fourrey, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 11 (18), 2507-2510<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7305081818808399610" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:B3FOqHPlNUQC" class="gsc_a_at">Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus</a><div class="gs_gray">S Meneghesso, E Vanderlinden, A Stevaert, C McGuigan, J Balzarini, ...</div><div class="gs_gray">Antiviral research 94 (1), 35-43<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=951810267246236037" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:NhqRSupF_l8C" class="gsc_a_at">An investigation into the anti-HIV activity of 2′, 3′-didehydro-2′, 3′-dideoxyuridine (d4U) and 2′, 3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’derivatives</a><div class="gs_gray">Y Mehellou, J Balzarini, C McGuigan</div><div class="gs_gray">Organic &amp; biomolecular chemistry 7 (12), 2548-2553<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5373839237414673842" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:XiSMed-E-HIC" class="gsc_a_at">A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2</a><div class="gs_gray">C Vanpouille, A Lisco, M Derudas, E Saba, JC Grive, B Brichacek, ...</div><div class="gs_gray">The Journal of infectious diseases 201 (4), 635-643<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13047571046998693817" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:2osOgNQ5qMEC" class="gsc_a_at">Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and&nbsp;…</a><div class="gs_gray">J Balzarini, R Sienaert, S Liekens, A Van Kuilenburg, A Carangio, ...</div><div class="gs_gray">Molecular pharmacology 61 (5), 1140-1145<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11495552654291047148" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:VOx2b1Wkg3QC" class="gsc_a_at">The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2′-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by&nbsp;…</a><div class="gs_gray">JV Voorde, S Liekens, C McGuigan, PGS Murziani, M Slusarczyk, ...</div><div class="gs_gray">Biochemical pharmacology 82 (5), 441-452<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6650532152808138122" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:f2IySw72cVMC" class="gsc_a_at">Phosphate derivatives of d4T as inhibitors of HIV</a><div class="gs_gray">C McGuigan, HM Sheeka, N Mahmood, A Hay</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 3 (6), 1203-1206<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6811357979412669380" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:BrmTIyaxlBUC" class="gsc_a_at">Novel Phosphoramidate Prodrugs of <i>N-</i>Acetyl-(<span class="gs_fscp">d</span>)-Glucosamine with Antidegenerative Activity on Bovine and Human Cartilage Explants</a><div class="gs_gray">M Serpi, R Bibbo, S Rat, H Roberts, C Hughes, B Caterson, MJ Alcaraz, ...</div><div class="gs_gray">Journal of medicinal chemistry 55 (10), 4629-4639<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16135500762989153014" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:b0M2c_1WBrUC" class="gsc_a_at">Design, synthesis, and anti-HIV activity of 2′, 3′-didehydro-2′, 3′-dideoxyuridine (d4U), 2′, 3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’derivatives</a><div class="gs_gray">Y Mehellou, C McGuigan, A Brancale, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 17 (13), 3666-3669<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12840741018679445804" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:UxriW0iASnsC" class="gsc_a_at">Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: design, synthesis and biological evaluation</a><div class="gs_gray">C Congiatu, C McGuigan, WG Jiang, G Davies, MD Mason</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 24 (5-7), 485-489<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16850898290894835768" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:a0OBvERweLwC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): the effect of terminal unsaturation in the side chain</a><div class="gs_gray">S Srinivasan, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 11 (3), 391-393<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4908456081683118724" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:eq2jaN3J8jMC" class="gsc_a_at">Diastereoselective synthesis of P-chirogenic phosphoramidate prodrugs of nucleoside analogues (ProTides) via copper catalysed reaction</a><div class="gs_gray">F Pertusati, C McGuigan</div><div class="gs_gray">Chemical Communications 51 (38), 8070-8073<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3610138229944549538" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:dshw04ExmUIC" class="gsc_a_at">Activation of <i>p16</i> Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2′-Deoxyzebularine</a><div class="gs_gray">CB Yoo, R Valente, C Congiatu, F Gavazza, A Angel, MA Siddiqui, ...</div><div class="gs_gray">Journal of medicinal chemistry 51 (23), 7593-7601<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15112466559805608762" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:CHSYGLWDkRkC" class="gsc_a_at">A QSAR study investigating the effect of l-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T</a><div class="gs_gray">MH Knaggs, C McGuigan, SA Harris, P Heshmati, D Cahard, IH Gilbert, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 10 (18), 2075-2078<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9712710527021417481" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:bFI3QPDXJZMC" class="gsc_a_at">Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin&nbsp;…</a><div class="gs_gray">D Siccardi, LE Kandalaft, M Gumbleton, C McGuigan</div><div class="gs_gray">Journal of Pharmacology and Experimental Therapeutics 307 (3), 1112-1119<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15482842318363331410" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:abG-DnoFyZgC" class="gsc_a_at">Diaryl phosphate derivatives act as pro-drugs of AZT with reduced cytotoxicity compared to the parent nucleoside</a><div class="gs_gray">C McGuigan, RN Pathirana, MPH Davies, J Balzarini, E De Clercq</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 4 (3), 427-430<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13702819412235040016" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:Y5dfb0dijaUC" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, J Balzarini, E De Clercq</div><div class="gs_gray">US Patent 7,019,135<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13104958249396664397" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:uWQEDVKXjbEC" class="gsc_a_at">Synthesis, properties, and biological activity of some nucleoside cyclic phosphoramidates</a><div class="gs_gray">AS Jones, C McGuigan, RT Walker, J Balzarini, E De Clercq</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 1471-1474<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=446845230865769280" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:LPZeul_q3PIC" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, C Yarnold, G Jones, J Balzarini, E De Clercq</div><div class="gs_gray">US Patent 6,573,247<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9736367922768401091" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=uaahAI4m4mMC:J-pR_7NvFogC" class="gsc_a_at">ProTides of <i>N</i>-(3-(5-(2′-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents</a><div class="gs_gray">C McGuigan, M Derudas, B Gonczy, K Hinsinger, S Kandil, F Pertusati, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 22 (9), 2816-2824<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8954775692975292714" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:KxtntwgDAa4C" class="gsc_a_at">Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase</a><div class="gs_gray">EP Tchesnokov, A Obikhod, I Massud, A Lisco, C Vanpouille, B Brichacek, ...</div><div class="gs_gray">Journal of Biological Chemistry 284 (32), 21496-21504<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6980592053855555546" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:eflP2zaiRacC" class="gsc_a_at">Antiviral purine derivatives</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 6,638,919<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15321541451564710447" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:nb7KW1ujOQ8C" class="gsc_a_at">Synthesis and antiviral activity of acyclovir-5′-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug</a><div class="gs_gray">C McGuigan, MJ Slater, NR Parry, A Perry, S Harris</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 10 (7), 645-647<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6143407582973530693" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:xtRiw3GOFMkC" class="gsc_a_at">Novel nucleoside phosphoramidates as inhibitors of HIV: studies on the stereochemical requirements of the phosphoramidate amino acid</a><div class="gs_gray">C McGuigan, A Salgado, C Yarnold, TY Harries, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 7 (4), 184-188<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9547087433036520706" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tkaPQYYpVKoC" class="gsc_a_at">Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides</a><div class="gs_gray">C McGuigan, C Bourdin, M Derudas, N Hamon, K Hinsinger, S Kandil, ...</div><div class="gs_gray">European journal of medicinal chemistry 70, 326-340<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13162244963449126223" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:u9iWguZQMMsC" class="gsc_a_at">Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs</a><div class="gs_gray">K Madela, C McGuigan</div><div class="gs_gray">Future medicinal chemistry 4 (5), 625-650<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9012554234176471719" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:NDuN12AVoxsC" class="gsc_a_at">Phosphoramidate derivatives of AZT as inhibitors of HIV: studies on the carboxyl terminus</a><div class="gs_gray">C McGuigan, RN Pathirana, SSM Choi, D Kinchington, TJ O'Connor</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 4 (2), 97-101<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3940674457157439918" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PR6Y55bgFSsC" class="gsc_a_at">PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer</a><div class="gs_gray">F Pertusati, K Hinsinger, ÁS Flynn, N Powell, A Tristram, J Balzarini, ...</div><div class="gs_gray">European journal of medicinal chemistry 78, 259-268<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6351553781158419955" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:1yQoGdGgb4wC" class="gsc_a_at">Phosphoramidate derivatives</a><div class="gs_gray">C McGuigan, A Carangio, B Caterson, CE Hughes, CL Curtis</div><div class="gs_gray">US Patent 8,119,779<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15657059721409516958" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:vRqMK49ujn8C" class="gsc_a_at">Successful kinase bypass with new acyclovir phosphoramidate prodrugs</a><div class="gs_gray">C McGuigan, M Derudas, JJ Bugert, G Andrei, R Snoeck, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 18 (15), 4364-4367<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14203854124168548499" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:K3LRdlH-MEoC" class="gsc_a_at">Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity</a><div class="gs_gray">A Angell, C McGuigan, LG Sevillano, R Snoeck, G Andrei, E De Clercq, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 14 (10), 2397-2399<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10400720639878009924" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:P5F9QuxV20EC" class="gsc_a_at">Anti-Varicella—Zoster Virus Bicyclic Nucleosides: Replacement of Furo by Pyrro Base Reduces Antiviral Potency</a><div class="gs_gray">C McGuigan, RN Pathirana, G Jones, G Andrei, R Snoeck, E De Clercq, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 11 (5), 343-348<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10824272297452415054" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:qxL8FJ1GzNcC" class="gsc_a_at">Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections</a><div class="gs_gray">C McGuigan, K Madela, C Bourdin, J Vernachio, S Chamberlain</div><div class="gs_gray">US Patent 9,351,989<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7258992571753864684" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:nRpfm8aw39MC" class="gsc_a_at">Mutant recombinant adeno-associated viruses</a><div class="gs_gray">M Vega, L Drittanti, M Flaux</div><div class="gs_gray">US Patent App. 10/022,390<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15817922517525762217" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Tiz5es2fbqcC" class="gsc_a_at">Activities of masked 2′, 3′-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages</a><div class="gs_gray">S Aquaro, O Wedgwood, C Yarnold, D Cahard, R Pathinara, C McGuigan, ...</div><div class="gs_gray">Antimicrobial agents and chemotherapy 44 (1), 173-177<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10970325389825123880" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:08ZZubdj9fEC" class="gsc_a_at">Synthesis and anti-HIV activity of some novel diaryl phosphate derivatives of AZT</a><div class="gs_gray">C McGuigan, M Davies, R Pathirana, N Mahmood, AJ Hay</div><div class="gs_gray">Antiviral research 24 (1), 69-77<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10153283428555458727" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:4fKUyHm3Qg0C" class="gsc_a_at">Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines</a><div class="gs_gray">MD Migliore, N Zonta, C McGuigan, G Henson, G Andrei, R Snoeck, ...</div><div class="gs_gray">Journal of medicinal chemistry 50 (26), 6485-6492<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=922686488163974915" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:zYLM7Y9cAGgC" class="gsc_a_at">Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5&nbsp;…</a><div class="gs_gray">J Balzarini, S Aquaro, A Hassan-Abdallah, SM Daluge, CF Perno, ...</div><div class="gs_gray">FEBS letters 573 (1-3), 38-44<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12931793567812786571" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:UeHWp8X0CEIC" class="gsc_a_at">Design, synthesis and biological evaluation of novel nucleotide prodrugs as inhibitors of HIV replication</a><div class="gs_gray">C McGuigan, MJ Camarasa, H Egberink, K Hartmann, A Karlsson, ...</div><div class="gs_gray">International Antiviral News 5 (2), 19-21<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13118724380011279865" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:wbdj-CoPYUoC" class="gsc_a_at">Phosphate derivatives of AZT display enhanced selectivity of action against HIV1 by comparison to the parent nucleoside</a><div class="gs_gray">C McGuigan, C Nickson, J Petrik, A Karpas</div><div class="gs_gray">FEBS letters 310 (2), 171-174<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14100183562738635946" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:JoZmwDi-zQgC" class="gsc_a_at">Synthesis of an apionucleoside family and discovery of a prodrug with anti-HIV activity</a><div class="gs_gray">KS Toti, M Derudas, F Pertusati, D Sinnaeve, F Van den Broeck, ...</div><div class="gs_gray">The Journal of organic chemistry 79 (11), 5097-5112<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12235253265360539988" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ZuybSZzF8UAC" class="gsc_a_at">Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents</a><div class="gs_gray">SM Daluge, C McGuigan</div><div class="gs_gray">US Patent 7,115,590<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15598887712989168530" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:5ugPr518TE4C" class="gsc_a_at">Synthesis and evaluation of some novel phosphate and phosphinate derivatives of araA. Studies on the mechanism of action of phosphate triesters</a><div class="gs_gray">C McGuigan, JM Shackleton, SM Tollerfield, PA Riley</div><div class="gs_gray">Nucleic acids research 17 (24), 10171-10177<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14969615498230952998" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:EkHepimYqZsC" class="gsc_a_at">Design, synthesis, and biological evaluation of C1–phosphonamidate analogues of 2-deoxy-d-ribose-1-phosphate</a><div class="gs_gray">M Quintiliani, J Balzarini, C McGuigan</div><div class="gs_gray">Tetrahedron 69 (43), 9111-9119<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3392672138517088002" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:8AbLer7MMksC" class="gsc_a_at">FV100 as a new approach for the possible treatment of varicella-zoster virus infection</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">Journal of antimicrobial chemotherapy 64 (4), 671-673<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=519158928060760584" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:1qzjygNMrQYC" class="gsc_a_at">The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4′-azidoinosine: Kinase bypass on a dual base&nbsp;…</a><div class="gs_gray">C McGuigan, F Daverio, I Nájera, JA Martin, K Klumpp, DB Smith</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 19 (11), 3122-3124<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8367230862636384773" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:1taIhTC69MYC" class="gsc_a_at">Battery-powered washer</a><div class="gs_gray">S Wong, N Glenn, W Rakocy, D Bean</div><div class="gs_gray">US Patent 6,984,901<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7841170743715618366,5014109786249436768" class="gsc_a_ac gs_ibl">24</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="uaahAI4m4mMC:1taIhTC69MYC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tS2w5q8j5-wC" class="gsc_a_at">Bicyclic nucleoside inhibitors of Varicella–Zoster virus: The effect of branching in the <i>p</i>-alkylphenyl side chain</a><div class="gs_gray">G Luoni, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 15 (16), 3791-3796<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18076305974817922150" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:AXPGKjj_ei8C" class="gsc_a_at">The differential expression of hCNT1 and hENT1 in breast cancer and the possible impact on breast cancer therapy.</a><div class="gs_gray">J Lane, TA Martin, C McGuigan, MD Mason, WG Jiang</div><div class="gs_gray">Journal of experimental therapeutics &amp; oncology 8 (3)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9295677077656180007" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:l7t_Zn2s7bgC" class="gsc_a_at">Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation</a><div class="gs_gray">C McGuigan, D Kinchington, MF Wang, SR Nicholls, C Nickson, S Galpin, ...</div><div class="gs_gray">FEBS letters 322 (3), 249-252<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=69715749040157052" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:vDijr-p_gm4C" class="gsc_a_at">7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer</a><div class="gs_gray">S Kandil, AD Westwell, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 26 (8), 2000-2004<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5127772088277761121" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:XiVPGOgt02cC" class="gsc_a_at">Phosphoramidate Protides of 2′, 3′-dideoxy-3′-fluoroadenosine and related nucleosides with potent activity against HIV and HBV</a><div class="gs_gray">KS Gudmundsson, SM Daluge, LC Johnson, R Jansen, R Hazen, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 22 (10), 1953-1961<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6020754999716001481" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tOudhMTPpwUC" class="gsc_a_at">Synthesis and anti-varicella-zoster virus activity of some novel bicyclic nucleoside inhibitors: effect of enhanced aqueous solubility</a><div class="gs_gray">A Brancale, S Srinivasan, C McGuigan, G Andrei, R Snoeck, E De Clercq, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 11 (6), 383-393<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4671110427326167316" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:V3AGJWp-ZtQC" class="gsc_a_at">Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents</a><div class="gs_gray">C McGuigan, A Perry, CJ Yarnold, PW Sutton, D Lowe, W Miller, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 9 (3), 233-243<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5536634895735597516" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:D_sINldO8mEC" class="gsc_a_at">Alkyl hydrogen phosphonate derivatives of the anti-HIV agent AZT may be less toxic than the parent nucleoside analogue</a><div class="gs_gray">C McGuigan, P Bellevergue, B Jones, N Mahmood, AJ Hay, J Petrik, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 5 (4), 271-277<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10971647564707739083" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_B80troHkn4C" class="gsc_a_at">Phosphate Prodrugs Derived from <i>N</i>-Acetylglucosamine Have Enhanced Chondroprotective Activity in Explant Cultures and Represent a New Lead in&nbsp;…</a><div class="gs_gray">C McGuigan, M Serpi, R Bibbo, H Roberts, C Hughes, B Caterson, ...</div><div class="gs_gray">Journal of medicinal chemistry 51 (18), 5807-5812<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2455947218669470417" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:IjCSPb-OGe4C" class="gsc_a_at">Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase</a><div class="gs_gray">R Sienaert, G Andrei, R Snoeck, E De Clercq, C McGuigan, J Balzarini</div><div class="gs_gray">Biochemical and biophysical research communications 315 (4), 877-883<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6643910411112142268" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:q3oQSFYPqjQC" class="gsc_a_at">Synthesis and anti-HIV activity of some novel lactyl and glycolyl phosphate derivatives</a><div class="gs_gray">C McGuigan, C Nickson, TJ O'Connor, D Kinchington</div><div class="gs_gray">Antiviral research 17 (3), 197-212<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8693941676040018475" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:5Ul4iDaHHb8C" class="gsc_a_at">Attempts to introduce chemotherapeutic nucleotides into cells: studies on the anti-HIV agent FDT</a><div class="gs_gray">C Mcguigan, BCNM Jones, KG Devine, SR Nicholls, D Kinchington</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 1 (12), 729-732<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3167246537995504465" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:9vf0nzSNQJEC" class="gsc_a_at">Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin</a><div class="gs_gray">C Vanpouille, A Lisco, A Introini, JC Grivel, A Munawwar, M Merbah, ...</div><div class="gs_gray">Antimicrobial agents and chemotherapy 56 (5), 2604-2611<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14421342409311768689" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:VL0QpB8kHFEC" class="gsc_a_at">Molecular modelling studies on the binding of some protides to the putative human phosphoramidase Hint1</a><div class="gs_gray">C Congiatu, A Brancale, C McGuigan</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 26 (8-9), 1121-1124<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11851211962882840283" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kRWSkSYxWN8C" class="gsc_a_at">Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine</a><div class="gs_gray">C McGuigan, L Bidois, A Hiouni, C Ballatore, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 11 (2), 111-116<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4342663666149507117" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HE397vMXCloC" class="gsc_a_at">Synthesis and biological evaluation of haloalkyl phosphate triester derivatives of araA and araC</a><div class="gs_gray">C McGuigan, B Jones, SM Tollerfield, PA Riley</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 3 (2), 79-84<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14060212801046377660" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ye4kPcJQO24C" class="gsc_a_at">Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: Monophenylboronic acids</a><div class="gs_gray">PC Trippier, C McGuigan, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 20 (6), 249-257<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10568967540972750026" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:N5tVd3kTz84C" class="gsc_a_at">Phosphoramidate Protides of carbocyclic 2′, 3′‐dideoxy‐2′, 3′‐didehydro‐7‐deazaadenosine with potent activity against HIV and HBV</a><div class="gs_gray">KS Gudmundsson, Z Wang, SM Daluge, LC Johnson, R Hazen, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 23 (12), 1929-1937<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14697367631636624592" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:fQNAKQ3IYiAC" class="gsc_a_at">A new and rapid synthesis of phospholipids</a><div class="gs_gray">C Mcguigan</div><div class="gs_gray">Journal of the Chemical Society, Chemical Communications, 533-534<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10391478110514839176" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Z5m8FVwuT1cC" class="gsc_a_at">Novel <i>cis</i>-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells</a><div class="gs_gray">S Kandil, JM Wymant, BM Kariuki, AT Jones, C McGuigan, AD Westwell</div><div class="gs_gray">European journal of medicinal chemistry 110, 311-325<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17607491233911794071" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:hkOj_22Ku90C" class="gsc_a_at">Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective varicella-zoster virus inhibitors</a><div class="gs_gray">S Blewett, C McGuigan, H Barucki, G Andrei, R Snoeck, E De Clercq, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 20 (4-7), 1063-1066<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9819580231841364560" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:t6usbXjVLHcC" class="gsc_a_at">Synthesis of some amino acid linked nitrogen mustard derivatives</a><div class="gs_gray">C Mcguigan, P Narashiman</div><div class="gs_gray">Synthesis 1993 (3), 311-314<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12517133685168911858" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:fEOibwPWpKIC" class="gsc_a_at">Novel Antiviral Activity of <span class="gs_fscp">l</span>-Dideoxy Bicyclic Nucleoside Analogues versus Vaccinia and Measles Viruses in Vitro</a><div class="gs_gray">C McGuigan, K Hinsinger, L Farleigh, RN Pathirana, JJ Bugert</div><div class="gs_gray">Journal of medicinal chemistry 56 (3), 1311-1322<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2427847233318770759" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:mvPsJ3kp5DgC" class="gsc_a_at">Preferential π–π complexation between tamoxifen and borage oil/γ linolenic acid: transcutaneous delivery and NMR spectral modulation</a><div class="gs_gray">CM Heard, SJ Gallagher, C Congiatu, J Harwood, CP Thomas, ...</div><div class="gs_gray">International journal of pharmaceutics 302 (1-2), 47-55<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2874273226482388794" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Mojj43d5GZwC" class="gsc_a_at">Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosine</a><div class="gs_gray">TM Griffith, AT Chaytor, DH Edwards, F Daverio, C McGuigan</div><div class="gs_gray">British journal of pharmacology 142 (1), 27-30<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7424261647134584824" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:bnK-pcrLprsC" class="gsc_a_at">Enhancing the aqueous solubility of d4T-based phosphoramidate prodrugs</a><div class="gs_gray">A Siddiqui, C McGuigan, C Ballatore, S Srinivasan, E De Clercq, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 10 (4), 381-384<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10054215431002971644" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:BUYA1_V_uYcC" class="gsc_a_at">Synthesis and biological evaluation of prodrugs of 2-fluoro-2-deoxyribose-1-phosphate and 2, 2-difluoro-2-deoxyribose-1-phosphate</a><div class="gs_gray">N Hamon, M Quintiliani, J Balzarini, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 23 (9), 2555-2559<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16011218049100095450" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tKAzc9rXhukC" class="gsc_a_at">Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acids</a><div class="gs_gray">PC Trippier, J Balzarini, C McGuigan</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 21 (3), 129-142<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1425245696987619964" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:YsMSGLbcyi4C" class="gsc_a_at">Topical delivery of retinyl ascorbate: 4. Comparative anti-oxidant activity towards DPPH</a><div class="gs_gray">K Abdulmajed, C McGuigan, CM Heard</div><div class="gs_gray">Free radical research 39 (5), 491-498<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12668572097900630638" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:eMMeJKvmdy0C" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Pd-catalysed synthesis of 5-aryl derivatives and their biological evaluation</a><div class="gs_gray">A Carangio, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 12 (3), 187-197<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9940654980727801996" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:SdhP9T11ey4C" class="gsc_a_at">Nucleic acid related compounds. 48. Photoaddition of methanol to 9-(. beta.-D-ribofuranosyl) purine (nebularine) to give inhibitors of adenosine deaminase.</a><div class="gs_gray">DK Buffel, C McGuigan, MJ Robins</div><div class="gs_gray">The Journal of Organic Chemistry 50 (15), 2664-2667<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2991659036258631679" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_Ybze24A_UAC" class="gsc_a_at">Synthesis of some nucleoside cyclic phosphoramidates and related compounds via phosphoramidites</a><div class="gs_gray">AS Jones, C McGuigan, RT Walker</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 199-202<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12966059036590497685" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:yB1At4FlUx8C" class="gsc_a_at">Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, K Mills, C Congiatu</div><div class="gs_gray">US Patent 8,263,575<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16791826145159079114" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:WA5NYHcadZ8C" class="gsc_a_at">Simple mono-derivatisation of the aryl moiety of D4A and DDA-based phosphoramidate prodrugs significantly enhances their anti-HIV potency in cell culture</a><div class="gs_gray">AQ Siddiqui, C McGuigan, C Ballatore, O Wedgwood, E De Clercq, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 9 (17), 2555-2560<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2022152609625079945" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:IUKN3-7HHlwC" class="gsc_a_at">Phosphoramidite derivatives of gemcitabine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan</div><div class="gs_gray">US Patent 9,321,798<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5921664439470196418" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:XD-gHx7UXLsC" class="gsc_a_at">Synthesis and Biological Evaluation of Purine 2′‐Fluoro‐2′‐deoxyriboside ProTides as Anti‐influenza Virus Agents</a><div class="gs_gray">S Meneghesso, E Vanderlinden, A Brancale, J Balzarini, L Naesens, ...</div><div class="gs_gray">ChemMedChem 8 (3), 415-425<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10353856768615191001" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:U_HPUtbDl20C" class="gsc_a_at">Comparison of Antiviral Effects of Zidovudine Phosphoramidate and Phosphorodiamidate Derivatives against HIV and ULV <i>in vitro</i></a><div class="gs_gray">D Kinchington, JJ Harvey, TJ O'Connor, B Jones, KG Devine, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 3 (2), 107-112<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4089774211411713023" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HbR8gkJAVGIC" class="gsc_a_at">Anti‐flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues</a><div class="gs_gray">C McGuigan, M Serpi, M Slusarczyk, V Ferrari, F Pertusati, S Meneghesso, ...</div><div class="gs_gray">ChemistryOpen 5 (3), 227<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9052661106953410459" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ALROH1vI_8AC" class="gsc_a_at">Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, J Balzarini, M Slusarczyk, B Gonczy, P Murziani</div><div class="gs_gray">US Patent 8,933,053<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1893482967103266522" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kzcrU_BdoSEC" class="gsc_a_at">Design, synthesis and biological evaluation of 2′-deoxy-2′, 2′-difluoro-5-halouridine phosphoramidate ProTides</a><div class="gs_gray">M Quintiliani, L Persoons, N Solaroli, A Karlsson, G Andrei, R Snoeck, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 19 (14), 4338-4345<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7373223566047201696" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:UHK10RUVsp4C" class="gsc_a_at">A phosphoramidate ProTide (NUC-1031) and acquired and intrinsic resistance to gemcitabine.</a><div class="gs_gray">C McGuigan, NA Habib, HS Wasan, H Gabra, LR Jiao, M Slusarczyk, ...</div><div class="gs_gray">Journal of Clinical Oncology 29 (15_suppl), e13540-e13540<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2235525018718631236" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:W7OEmFMy1HYC" class="gsc_a_at">In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skin</a><div class="gs_gray">CA Jarvis, C McGuigan, CM Heard</div><div class="gs_gray">Pharmaceutical research 21 (6), 914-919<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9980704176638150921" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:5awf1xo2G04C" class="gsc_a_at">Novel bicyclic furanopyrimidines with dual anti-VZV and-HCMV activity</a><div class="gs_gray">C McGuigan, A Brancale, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 13 (24), 4511-4513<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5825932423624209387" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:dTyEYWd-f8wC" class="gsc_a_at">Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection</a><div class="gs_gray">J Balzarini, D Cahard, O Wedgwood, A Salgado, S Velázquez, ...</div><div class="gs_gray">JAIDS Journal of Acquired Immune Deficiency Syndromes 17 (4), 296-302<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13265880072270112162" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:sJsF-0ZLhtgC" class="gsc_a_at">Virtual screening of acyclovir derivatives as potential antiviral agents: design, synthesis, and biological evaluation of new acyclic nucleoside ProTides</a><div class="gs_gray">M Derudas, C Vanpouille, D Carta, S Zicari, G Andrei, R Snoeck, ...</div><div class="gs_gray">Journal of medicinal chemistry 60 (18), 7876-7896<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16826541741622404314" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:M3ejUd6NZC8C" class="gsc_a_at">Kinase-independent phosphoramidate S1P1 receptor agonist benzyl ether derivatives</a><div class="gs_gray">E James, F Pertusati, A Brancale, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 27 (6), 1371-1378<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6286766890255814214" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ZzlSgRqYykMC" class="gsc_a_at">ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites</a><div class="gs_gray">S Kandil, J Balzarini, S Rat, A Brancale, AD Westwell, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 26 (23), 5618-5623<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13922701481195571866" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:LjlpjdlvIbIC" class="gsc_a_at">Lactate cannot substitute for alanine in d4T-based anti-HIV nucleotide prodrugs-despite efficient esterase-mediated hydrolysis</a><div class="gs_gray">C McGuigan, D Cahard, C Ballatore, A Siddiqui, E De Clercq, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 8 (21), 2949-2954<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8320281047236785619" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:sszUF3NjhM4C" class="gsc_a_at">Haloalkyl phosphate derivatives of AZT as inhibitors of HIV: studies in the phosphate region</a><div class="gs_gray">C McGuigan, S Turner, SR Nicholls, TJ O'Connor, D Kinchington</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 5 (3), 162-168<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9207610071198581920" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:EYYDruWGBe4C" class="gsc_a_at">Rational design and synthesis of novel anti-prostate cancer agents bearing a 3, 5-bis-trifluoromethylphenyl moiety</a><div class="gs_gray">S Ferla, M Bassetto, F Pertusati, S Kandil, AD Westwell, A Brancale, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 26 (15), 3636-3640<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7583449466505135478" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:NJ774b8OgUMC" class="gsc_a_at">Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against varicella zoster virus</a><div class="gs_gray">C McGuigan, O Bidet, M Derudas, G Andrei, R Snoeck, J Balzarini</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 17 (8), 3025-3027<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12044463938728404092" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:j8SEvjWlNXcC" class="gsc_a_at">Nucleoside Analogues of Cladribine Produce Enhanced Responses in Cell Lines.</a><div class="gs_gray">E Walsby, C Congiatu, A Schwappach, V Walsh, AK Burnett, C McGuigan, ...</div><div class="gs_gray">Blood 106 (11), 3369<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13062742600010472780" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Y0pCki6q_DkC" class="gsc_a_at">Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV)</a><div class="gs_gray">R Sienaert, L Naesens, A Brancale, A Carangio, G Andrei, R Snoeck, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 22 (5-8), 995-997<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9771491722990561635" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:dQ2og3OwTAUC" class="gsc_a_at">Simple phospholipids have selective anti-HIV activity</a><div class="gs_gray">C McGuigan, TJ O'Connor, B Swords, D Kinchington</div><div class="gs_gray">Aids 5 (12), 1536-1537<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1942062386526795848" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:rHJHxKgnXwkC" class="gsc_a_at">A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative&nbsp;…</a><div class="gs_gray">F Pertusati, S Ferla, M Bassetto, A Brancale, S Khandil, AD Westwell, ...</div><div class="gs_gray">European journal of medicinal chemistry 180, 1-14<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15986370278516281838" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_Re3VWB3Y0AC" class="gsc_a_at">Synthesis and antiviral evaluation of α-l-2′-deoxythreofuranosyl nucleosides</a><div class="gs_gray">KS Toti, M Derudas, C McGuigan, J Balzarini, S Van Calenbergh</div><div class="gs_gray">European journal of medicinal chemistry 46 (9), 3704-3713<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3839127615986757008" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:0KyAp5RtaNEC" class="gsc_a_at">Evaluation of novel phosphoramidate ProTides of the 2′-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue</a><div class="gs_gray">M Derudas, M Quintiliani, A Brancale, G Andrei, R Snoeck, J Balzarini, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 21 (1), 15-31<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18050636822613417020" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:2KloaMYe4IUC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3′ and 5′ derivatives</a><div class="gs_gray">GM Luoni, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 15 (6), 333-341<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12103663384266183971" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:-_dYPAW6P2MC" class="gsc_a_at">Preparation of novel N-substituted phospholipids via phosphoramidite intermediates</a><div class="gs_gray">C McGuigan, B Swords</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 51-55<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=730741016370795179" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:W5xh706n7nkC" class="gsc_a_at">Trans-esterification reactions yield novel masked phosphate derivatives of the anti-cancer agent araC</a><div class="gs_gray">C McGuigan, BCNM Jones, PA Riley</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 1 (11), 607-610<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17865416861855650546" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:AXkvAH5U_nMC" class="gsc_a_at">Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity</a><div class="gs_gray">S Kandil, C Pannecouque, FM Chapman, AD Westwell, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 29 (24), 126721<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5083724042188232632" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:4xDN1ZYqzskC" class="gsc_a_at">Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides</a><div class="gs_gray">M Slusarczyk, S Ferla, A Brancale, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 26 (3), 551-565<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16225442045704337934" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:lmc2jWPfTJgC" class="gsc_a_at">Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, J Balzarini, M Slusarczyk, B Gonczy, P Murziani</div><div class="gs_gray">US Patent 9,221,866<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11521194405593247354" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:BwyfMAYsbu0C" class="gsc_a_at">Synthesis and evaluation against hepatitis C virus of 7-deaza analogues of 2′-<i>C</i>-methyl-6-<i>O</i>-methyl guanosine nucleoside and l-Alanine ester phosphoramidates</a><div class="gs_gray">C Bourdin, C McGuigan, A Brancale, S Chamberlain, J Vernachio, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 23 (7), 2260-2264<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2814313031889414046" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:7T2F9Uy0os0C" class="gsc_a_at">ProGem1: Phase 1 first-in-human study of the novel nucleotide analogue NUC-1031 in adult patients with advanced solid tumors</a><div class="gs_gray">EA Ghazaly, J Simon, JG Gribben, T Mohammad, E Oluwadunni, ...</div><div class="gs_gray">2013 ASCO Annual Meeting J. Clin. Oncol 31<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12730403187420220508" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:uLbwQdceFCQC" class="gsc_a_at">Synthesis and Antiviral Evaluation of Some 3′‐Fluoro Bicyclic Nucleoside Analogues</a><div class="gs_gray">C McGuigan, A Carangio, R Snoeck, G Andrei, E De Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 23 (1-2), 1-5<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8835055065745858050" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:JQOojiI6XY0C" class="gsc_a_at">Synthesis of phospholipids by phosphoramidite methodology</a><div class="gs_gray">C McGuigan, B Swords</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 783-787<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2368788670925391321" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:IaI1MmNe2tcC" class="gsc_a_at">Cancer treatments based on gemcitabine prodrugs</a><div class="gs_gray">H Griffith, C McGuigan, C Pepper</div><div class="gs_gray">US Patent App. 15/573,969<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6330803310080329715" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:hCrLmN-GePgC" class="gsc_a_at">Abstract B46: NUC-3373: A novel pyrimidine nucleotide analogue that overcomes key cancer drug resistance limiting patient survival</a><div class="gs_gray">EA Ghazaly, M Slusarczyk, C McGuigan, D Harrison, SP Blagden</div><div class="gs_gray">Molecular Cancer Therapeutics 14 (12 Supplement 2), B46-B46<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14224848889757523526" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tYavs44e6CUC" class="gsc_a_at">A novel radiochemical approach to 1‐(2'‐deoxy‐2'‐[<sup>18</sup>F]fluoro‐β‐<span class="gs_fscp">d</span>‐arabinofuranosyl)cytosine (<sup>18</sup>F‐FAC)</a><div class="gs_gray">JP Meyer, KC Probst, IML Trist, C McGuigan, AD Westwell</div><div class="gs_gray">Journal of Labelled Compounds and Radiopharmaceuticals 57 (11), 637-644<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6564707808740619670" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:g3aElNc5_aQC" class="gsc_a_at">Synthesis, anti-HIV and cytostatic evaluation of 3′-deoxy-3′-fluorothymidine (FLT) pro-nucleotides</a><div class="gs_gray">W Velanguparackel, N Hamon, J Balzarini, C McGuigan, AD Westwell</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 24 (10), 2240-2243<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1169600854325872914" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:nrtMV_XWKgEC" class="gsc_a_at">Inhibition of pyrimidine and purine nucleoside phosphorylases by a 3, 5-dichlorobenzoyl-substituted 2-deoxy-d-ribose-1-phosphate derivative</a><div class="gs_gray">JV Voorde, M Quintiliani, C McGuigan, S Liekens, J Balzarini</div><div class="gs_gray">Biochemical pharmacology 83 (10), 1358-1363<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12251118999114806576" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tzM49s52ZIMC" class="gsc_a_at">2′-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743</a><div class="gs_gray">C McGuigan, M Derudas, M Quintiliani, G Andrei, R Snoeck, G Henson, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 19 (22), 6264-6267<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7643343270006546683,495591054665183167" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:uJ-U7cs_P_0C" class="gsc_a_at">The journey towards elucidating the anti-HCMV activity of alkylated bicyclic furano pyrimidines</a><div class="gs_gray">MR Kelleher, C McGuigan, O Bidet, A Carangio, H Weldon, G Andrei, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 24 (5-7), 643-645<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18399765823224203293" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:AvfA0Oy_GE0C" class="gsc_a_at">Metabolism and anti-HIV activity of phosphoramidate derivatives of d4T-MP with variations in the amino acid moiety</a><div class="gs_gray">L Naesens, D Cahard, A Salgado, L Bidois, E De Clercq, C McGuigan, ...</div><div class="gs_gray">Purine and Pyrimidine Metabolism in Man IX, 753-757<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11010419762491956710" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:evX43VCCuoAC" class="gsc_a_at">Synthesis and Evaluation of 5-Halo 2′, 3′-Didehydro-2′, 3′-Dideoxynucleosides and their Blocked Phosphoramidates as Potential Anti-Human Immunodeficiency virus Agents: An&nbsp;…</a><div class="gs_gray">C McGuigan, S Velazquez, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 8 (6), 519-527<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13884629310007751090" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:F9fV5C73w3QC" class="gsc_a_at">Gemcitabine prodrugs</a><div class="gs_gray">H Griffith, C McGuigan, M Slusarczyk, M Serpi, V Ferrari</div><div class="gs_gray">US Patent 10,662,213<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13395742707107520659" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:j7_hQOaDUrUC" class="gsc_a_at">Process for preparing nucleoside prodrugs</a><div class="gs_gray">C McGuigan, F Pertusati</div><div class="gs_gray">US Patent App. 15/994,378<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=58170122174024360" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:TIZ-Mc8IlK0C" class="gsc_a_at">Chemoselective <i>N-</i>Deacetylation of Protected Nucleosides and Nucleotides Promoted by Schwartz's Reagent</a><div class="gs_gray">V Ferrari, M Serpi, C McGuigan, F Pertusati</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 34 (11), 799-814<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8411924167278000239" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:xtoqd-5pKcoC" class="gsc_a_at">Synthesis and biological evaluation of phosphoramidate prodrugs of two analogues of 2-deoxy-D-ribose-1-phosphate directed to the discovery of two carbasugars as new potential&nbsp;…</a><div class="gs_gray">N Hamon, M Slusarczyk, M Serpi, J Balzarini, C McGuigan</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry 23 (4), 829-838<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8687194175610466392" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ubry08Y2EpUC" class="gsc_a_at">Anti-viral pyrimidine nucleoside derivatives</a><div class="gs_gray">C McGuigan, J Balzarini, M Migliore</div><div class="gs_gray">US Patent 8,329,664<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5038856292302361554" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:uWiczbcajpAC" class="gsc_a_at">The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-β-D-(arabinofuranosyl) uracil phosphoramidate ProTides</a><div class="gs_gray">Y Mehellou, J Balzarini, C McGuigan</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 20 (4), 153-160<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8488378434094554993" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:WF5omc3nYNoC" class="gsc_a_at">Synthesis and biological evaluation of N-and O-alkylated bicyclic furanopyrimidines as non-nucleosidic inhibitors of human cytomegalovirus</a><div class="gs_gray">MR Kelleher, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 24 (5-7), 639-641<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12885830460221956799,14565256019003586578" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:35r97b3x0nAC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus: 5′-chloro and 3′-chloro derivatives</a><div class="gs_gray">G Luoni, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 22 (5-8), 931-933<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11425574210453968" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:t7zJ5fGR-2UC" class="gsc_a_at">Halophenyl furanopyrimidines as potent and selective anti-VZV agents</a><div class="gs_gray">C McGuigan, A Jukes, S Blewett, H Barucki, JT Erichsen, G Andrei, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 14 (3), 165-170<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7650051296856782982" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:7Hz3ACDFbsoC" class="gsc_a_at">Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, J Balzarini, M Slusarczyk, B Gonczy, P Murziani</div><div class="gs_gray">US Patent 9,655,915<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13416739410405500026" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ruyezt5ZtCIC" class="gsc_a_at">Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.</a><div class="gs_gray">SP Blagden, I Rizzuto, C Stavraka, D O'Shea, P Suppiah, M Patel, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 2514-2514<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10148468650362081232" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:vbGhcppDl1QC" class="gsc_a_at">A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.</a><div class="gs_gray">SP Blagden, I Rizzuto, C Stavraka, D O'Shea, P Suppiah, M Patel, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 2547-2547<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7301636715252784665" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Dip1O2bNi0gC" class="gsc_a_at">Abstract CT401: NUC-1031: A novel ProTide that overcomes the key cancer resistance mechanisms associated with poor survival</a><div class="gs_gray">EA Ghazaly, M Slusarczyk, M Mason, J Gribben, C McGuigan, S Blagden</div><div class="gs_gray">Cancer Research 74 (19 Supplement), CT401-CT401<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8590098521485351389" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:z_wVstp3MssC" class="gsc_a_at">Characterization of in vitro selected hepatitis C virus replicon mutants resistant to the phosphoramidate analog of 2'-C-Methylguanosine, INX-189</a><div class="gs_gray">A Kolykhalov, Y Liu, B Bleiman, J Patti, C McGuigan, J Vernachio</div><div class="gs_gray">Hepatology 52 (S1), 1218A-1218A<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7218882788306600143" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ufrVoPGSRksC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus: synthesis and biological evaluation of 2′, 3′-dideoxy-3′-fluoro and 2′-deoxy-xylo derivatives</a><div class="gs_gray">A Carangio, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 22 (5-8), 935-937<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14251854404344286376" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:VLnqNzywnoUC" class="gsc_a_at">Alkyloxyphenyl furano pyrimidines as potent and selective anti-VZV agents with enhanced water solubility</a><div class="gs_gray">C McGuigan, S Blewett, D Siccardi, JT Erichsen, G Andrei, R Snoek, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 13 (2), 91-99<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=31676490655048200" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:NyGDZy8z5eUC" class="gsc_a_at">Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, J Balzarini, M Slusarczyk, B Gonczy, P Murziani</div><div class="gs_gray">US Patent 10,022,390<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17564398144557725433" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:F1b5ZUV5XREC" class="gsc_a_at">Synthetic Approaches for the Preparation of Phosphoramidate Prodrugs of 2′‐Deoxypseudoisocytidine</a><div class="gs_gray">M Serpi, R De Biasi, F Pertusati, M Slusarczyk, C McGuigan</div><div class="gs_gray">ChemistryOpen 6 (3), 424<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18250245693607255279" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:5icHVeHT4IsC" class="gsc_a_at">Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery</a><div class="gs_gray">F Pertusati, C McGuigan, M Serpi</div><div class="gs_gray">Current protocols in nucleic acid chemistry 60 (1), 15.6. 1-15.6. 10<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15625815920220119040" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_FxGoFyzp5QC" class="gsc_a_at">Targeted dermal delivery of highly potent anti-varicella zoster virus nucleoside analogues from saturated solutions and ethanolic oil-in-water creams</a><div class="gs_gray">CA Jarvis, CM Heard, C McGuigan</div><div class="gs_gray">Journal of drug targeting 11 (7), 433-441<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14437550784918581404" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PVjk1bu6vJQC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain</a><div class="gs_gray">A Carangio, S Srinivasan, C McGuigan, G Andrei, R Snoeck, E De Clercq, ...</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 13 (5), 263-271<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14693884276270709837" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:uc_IGeMz5qoC" class="gsc_a_at">A New Protocol for the Removal of Dimethoxytrityl Ether Groups Derived from Primary Alcohols</a><div class="gs_gray">Y Wang, C McGuigan</div><div class="gs_gray">Synthetic communications 27 (22), 3829-3833<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=336849320339623245" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ipzZ9siozwsC" class="gsc_a_at">Anti-HIV activity and metabolism of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety.</a><div class="gs_gray">L Naesens, D Cahard, A Salgado, L Bidois, E De Clerco, C McGuigan, ...</div><div class="gs_gray">Antiviral Research 34 (2), A54-A54<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=875455000781725810" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ML0RJ9NH7IQC" class="gsc_a_at">Synthesis and Evaluation of Some Symmetrical Phosphate Dimer Derivatives of 3′-Modified Nucleosides as Potential anti-HIV Agents</a><div class="gs_gray">C McGuigan, HW Tsang, N Mahmood, AJ Hay</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 7 (6), 330-337<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18008770303306215850" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kuK5TVdYjLIC" class="gsc_a_at">Synthesis and biological evaluation of substituted phosphate triester alkyl lyso phospholipids (ALPs) as novel potential anti-neoplastic agents</a><div class="gs_gray">C McGuigan, Y Wang, PA Riley</div><div class="gs_gray">FEBS letters 372 (2-3), 259-263<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9093770262145998665" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:URolC5Kub84C" class="gsc_a_at">Phase behaviour of novel phospholipid analogues</a><div class="gs_gray">GS Attard, C McGuigan, A Mackenzie</div><div class="gs_gray">Chemistry and physics of lipids 76 (1), 41-48<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9988246915396095668" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:4MWp96NkSFoC" class="gsc_a_at">Synthesis and biological evaluation of phosphate triester alkyl lysophospholipids (ALPs) as novel potential anti-neoplastic agents.</a><div class="gs_gray">C McGuigan, Y Wang, PA Riley</div><div class="gs_gray">Anti-cancer drug design 9 (6), 539-548<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1062787932223590438" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:OBSaB-F7qqsC" class="gsc_a_at">Radiosynthesis of [18F]-labelled pro-nucleotides (ProTides)</a><div class="gs_gray">A Cavaliere, KC Probst, SJ Paisey, C Marshall, AKH Dheere, F Aigbirhio, ...</div><div class="gs_gray">Molecules 25 (3), 704<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12624821892926185820" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:q-HalDI95KYC" class="gsc_a_at">Phosphoramidate compounds and methods of use</a><div class="gs_gray">C McGuigan</div><div class="gs_gray">US Patent App. 15/279,611<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10509763784597759821" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:7BrZ7Jt4UNcC" class="gsc_a_at">Symmetrical diamidates as a class of phosphate prodrugs to deliver the 5'-monophosphate form of anticancer nucleoside analogues</a><div class="gs_gray">M Slusarczyk, V Ferrari, M Serpi, B Gonczy, J Balzarini, C McGuigan</div><div class="gs_gray">ChemMedChem 13 (21), 2305-2316<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3375621480648583304" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_FM0Bhl9EiAC" class="gsc_a_at">Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agents</a><div class="gs_gray">M Bassetto, S Ferla, G Giancotti, F Pertusati, AD Westwell, A Brancale, ...</div><div class="gs_gray">MedChemComm 8 (7), 1414-1420<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1833956322678128597" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:UebtZRa9Y70C" class="gsc_a_at">Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral Infections</a><div class="gs_gray">S Chamberlain, J Vernachio, SK Battina, CVS Ramamurty, CS Rao, ...</div><div class="gs_gray">US Patent App. 14/357,358<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2460681174132123493" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:WAzi4Gm8nLoC" class="gsc_a_at">Chemical compounds</a><div class="gs_gray">C McGuigan, JJ Bugert, AT Jones, R Pathirana, LE Farleigh</div><div class="gs_gray">US Patent 8,551,966<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3632342389893791803" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:zLWjf1WUPmwC" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 8,551,965<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3833196136228557361" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Se3iqnhoufwC" class="gsc_a_at">Topical delivery of retinyl ascorbate co-drug: 6. Determination of toxic dose and antioxidant activity in cultured human epidermal keratinocytes.</a><div class="gs_gray">K Abdulmajed, C McGuigan, CM Heard</div><div class="gs_gray">Die Pharmazie 60 (10), 794-795<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14199936899078892774" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tuHXwOkdijsC" class="gsc_a_at">Synthesis of unusual bicyclic nucleosides bearing an unsaturated side-chain, as potential inhibitors of varicella-zoster virus (VZV)</a><div class="gs_gray">O Bidet, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 22 (5-8), 817-819<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11079639248854403705" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:9Nmd_mFXekcC" class="gsc_a_at">Synthesis and in vitro evaluation of novel anti-varicella-zoster virus (VZV) nucleosides</a><div class="gs_gray">A Carangio, C McGuigan, D Cahard, G Andrei, R Snoeck, E De Clercq, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 20 (4-7), 653-656<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11842504045329401566" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ILKRHgRFtOwC" class="gsc_a_at">Ara-A-5'-phenyl methoxy alaninyl phosphate as a prodrug of the Adenine arabinoside-monophosphate: synthesis and anti viral evaluation.</a><div class="gs_gray">C Ballatore, C McGuigan, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Research 46 (1), A63-A63<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1221035879266630280" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:k8Z6L05lTy4C" class="gsc_a_at">An in situ pig liver esterase assay as a useful predictive tool for the likely in vitro anti viral activity of phosphoramidate pro-drugs</a><div class="gs_gray">C Ballatore, C McGuigan, ED Clercq, J Balzarini</div><div class="gs_gray">Nucleosides, Nucleotides &amp; Nucleic Acids 18 (4-5), 967-969<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15277557961354799950" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:p__nRnzSRKYC" class="gsc_a_at">A rapid synthesis of some 5′-amino-nucleosides and nucleotides as potential antiviral compounds</a><div class="gs_gray">C McGuigan, S Turner, N Mahmood, AJ Hay</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 6 (20), 2445-2448<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5180448626627147217" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:L7CI7m0gUJcC" class="gsc_a_at">Permeability of CACO-2 to novel d4T-monophosphate prodrugs</a><div class="gs_gray">G O'leary, Z Degim, M Gumbleton, C Mcguigan</div><div class="gs_gray">European Journal of Pharmaceutical Sciences, S194<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10584893566740150998" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:MLfJN-KU85MC" class="gsc_a_at">A high yield synthesis of phosphatidyl ethanolamines using phosphoramidite intermediates</a><div class="gs_gray">C Mcguigan, B Swords</div><div class="gs_gray">Synthesis 1993 (01), 133-136<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11312651789984040687" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:3bvyWxjaHKcC" class="gsc_a_at">Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer</a><div class="gs_gray">SB Kandil, C McGuigan, AD Westwell</div><div class="gs_gray">Molecules 26 (1), 56<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18329733034232107305" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HhcuHIWmDEUC" class="gsc_a_at">Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials</a><div class="gs_gray">F Pertusati, E Pileggi, J Richards, M Wootton, T Van Leemputte, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 75 (10), 2864-2878<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11627649332760581629" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:umqufdRvDiIC" class="gsc_a_at">Anti-viral pyrimidine nucleoside derivatives</a><div class="gs_gray">C McGuigan, J Balzarini, M Migliore</div><div class="gs_gray">US Patent 9,427,447<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4559070589062513541" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:WJVC3Jt7v1AC" class="gsc_a_at">A phase Ib study of NUC1031 and carboplatin for patients with recurrent ovarian cancer.</a><div class="gs_gray">SP Blagden, A Sukumaran, C Gnanaranjan, MR Middleton, H Gabra, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 5565-5565<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5254023887714990961" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:LO7wyVUgiFcC" class="gsc_a_at">Compounds and methods for the treatment of viral infection</a><div class="gs_gray">L Margolis, J Balzarini, C McGuigan, A Lisco, C Vanpouille, M Derudas</div><div class="gs_gray">US Patent 8,946,243<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2343980856879311413" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:epqYDVWIO7EC" class="gsc_a_at">Anti-viral pyrimidine nucleoside derivatives</a><div class="gs_gray">C McGuigan, J Balzarini, M Migliore</div><div class="gs_gray">US Patent 8,859,512<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=619758514034940867" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:edDO8Oi4QzsC" class="gsc_a_at">Serendipity and VZV drug discovery</a><div class="gs_gray">M Derudas, C McGuigan</div><div class="gs_gray">Drug Discovery Today: Technologies 9 (3), e177-e181<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11480761743050759792" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:86PQX7AUzd4C" class="gsc_a_at">DMPK and metabolism studies of nucleoside phosphoramidates including INX-08189, a novel double pro-drug and clinical candidate for hepatitis C virus therapy</a><div class="gs_gray">JT Hutchins, C McGuigan, SD Chamberlain, KW Madela, M Aljarah, ...</div><div class="gs_gray">Antiviral Research 90 (2), A22-A23<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16772914231379198066" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:-FonjvnnhkoC" class="gsc_a_at">In vitro and in vivo metabolism of INX-189, a potent HCV inhibitor, in rat and cynomolgus monkey hepatocytes</a><div class="gs_gray">J Vernachio, D Bryant, SD Chamberlain, E Gorovits, BS Ganguly, A Hall, ...</div><div class="gs_gray">Hepatology 52 (S1), 1218A-1219A<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2701211902325501835" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:SjuI4pbJlxcC" class="gsc_a_at">Pharmacological properties and in vitro characterization of INX-189, a liver targeted phosphoramidate nucleoside analogue inhibitor of NS5b</a><div class="gs_gray">J Patti, B Ames, D Bryant, SD Chamberlain, BS Ganguly, E Gorovits, ...</div><div class="gs_gray">60th Annual Meeting of the American Association for the Study of Liver&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9027344033941139862" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:e_rmSamDkqQC" class="gsc_a_at">In vitro activity and in vivo pharmacokinetics of highly potent phosphoramidate nucleoside analogue inhibitors of hepatitis C NS5B</a><div class="gs_gray">J Hutchins, S Chanberlain, C Chang, B Ganguly, E Gorovits, A Hall, ...</div><div class="gs_gray">Antiviral Research 82 (2), A28<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3341936031526907278" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kz9GbA2Ns4gC" class="gsc_a_at">SAR of alkyloxyphenyl furano pyrimidines: potent and selective anti-VZV agents</a><div class="gs_gray">R Adak, B Mollwitz, M Migliore, C McGuigan, R Snoeck, G Andrei, ...</div><div class="gs_gray">Antiviral research 70 (1), A66-A66<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15887992412647235201" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:KUbvn5osdkgC" class="gsc_a_at">Pre-clinical development of the BCNAs: The most potent anti-VZV agents reported to date</a><div class="gs_gray">C McGuigan, R Pathirana, M Migliore, R Adak, A Angell, G Henson, ...</div><div class="gs_gray">Antiviral research, 70 70 (1), A31-A31<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4838127172862198505" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:VaXvl8Fpj5cC" class="gsc_a_at">Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents</a><div class="gs_gray">C McGuigan, H Barucki, A Carangio, S Blewett, S Srinivasan, G Andrei, ...</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 20 (4-7), 287-296<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14579553073097899917" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:gsN89kCJA0AC" class="gsc_a_at">Novel bicyclic fluorescent nucleosides as potent and selective inhibitors of VZV</a><div class="gs_gray">C McGuigan, CJ Yarnold, G Jones, S Velazquez, H Barucki, A Brancale, ...</div><div class="gs_gray">Antiviral research 46 (1), A73-A73<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8726818754538588644" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:b1wdh0AR-JQC" class="gsc_a_at">The Synthesis of Some N-Linked Phospholipid Analogues via Phosphorodiamidate Heterocyclic Intermediates</a><div class="gs_gray">C McGuigan, A Mackenzie</div><div class="gs_gray">Synthesis 1996 (11), 1331-1335<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10020708441095036801" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:XUvXOeBm_78C" class="gsc_a_at">First-in-human Phase I study of the nucleotide analogue NUC-3373 designed to overcome fluoropyrimidine drug resistance mechanisms</a><div class="gs_gray">SP Blagden, M Slusarczyk, M Serpi, C McGuigan, EA Ghazaly</div><div class="gs_gray">CANCER RESEARCH 76<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6971527078960096355" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:jgBuDB5drN8C" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent 9,351,970<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6499096893473699105" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:QD3KBmkZPeQC" class="gsc_a_at">First In Human Phase I study of NUC-3373, a nucleotide analogue designed to overcome fluoropyrimidine drug resistance mechanisms</a><div class="gs_gray">SP Blagden, M Slusarczyk, M Serpi, C McGuigan, EA Ghazaly</div><div class="gs_gray">Abstract CT028 Poster AACR<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6189076312523259473" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:WZBGuue-350C" class="gsc_a_at">Application of ProTide technology to gemcitabine: A successful approach to overcome key cancer resistance mechanism</a><div class="gs_gray">M Slusarczyk, C McGuigan</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 242<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2013937617344338304" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:0N-VGjzr574C" class="gsc_a_at">Metabolite characterization of INX-189, a potent HCV inhibitor, in fresh human primary hepatocytes and human liver and kidney cell lines [abstract 1874]</a><div class="gs_gray">A Hall, N Raja, SD Chamberlain, E Gorovits, GW Henson, JT Hutchins, ...</div><div class="gs_gray">Hepatology 52 (S1), 1211A-1211A<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17116296891719691476" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:FPJr55Dyh1AC" class="gsc_a_at">The application of phosphoramidate Protide technology to acyclovir confers novel anti-HIV inhibition</a><div class="gs_gray">M Derudas, C McGuigan, A Brancale, L Margolis, J Balzarini</div><div class="gs_gray">Antiviral research 82 (2), A57-A57<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13346125840074409029" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:XoXfffV-tXoC" class="gsc_a_at">Application of the phosphoramidate protide approach to the antiviral drug ribavirin</a><div class="gs_gray">M Derudas, C McGuigan, A Brancale, J Neyts, J Balzarini</div><div class="gs_gray">Antiviral Research 78 (2)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10949329732652226455" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:M7yex6snE4oC" class="gsc_a_at">MEDI 313-Enhancement of the anticancer activity of cladribine by application of the phosphoramidate protide approach</a><div class="gs_gray">R Valente, C Congiatu, E Walsby, K Mills, C McGuigan</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 234<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1235483927634460743" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:oNZyr7d5Mn4C" class="gsc_a_at">Heterocyclic compounds for use in the treatment of viral infections</a><div class="gs_gray">C McGuigan, J Balzarini, E De Clerq</div><div class="gs_gray">US Patent App. 10/551,569<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13468836413579342435" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:SpbeaW3--B0C" class="gsc_a_at">Enhancement of the anticancer activity of cladribine by application of the phosphoramidate protide approach</a><div class="gs_gray">R Valente, C Congiatu, E Walsby, K Mills, C McGuigan</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 233, 714-714<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5000485894012847834" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Ug5p-4gJ2f0C" class="gsc_a_at">Design and synthesis of novel anti-HCMV agents: Modifications to the bicyclic pyrimidine base</a><div class="gs_gray">R Adak, C McGuigan, R Snoeck, G Andrei, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Research 74 (3), A71<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11422518156784420311" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:q3CdL3IzO_QC" class="gsc_a_at">Phosphoramidate Derivatives of 2′, 5′-Dideoxyadenosine as Potential Inhibitors of the EDHF Phenomenon</a><div class="gs_gray">F Gavazza, F Daverio, AT Chaytor, TM Griffith, C McGuigan</div><div class="gs_gray">Nucleosides, Nucleotides and Nucleic Acids 24 (5-7), 553-555<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9721197808235809575" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:_axFR9aDTf0C" class="gsc_a_at">Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine family</a><div class="gs_gray">O Bidet, C McGuigan, R Snoeck, G Andrei, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Chemistry and Chemotherapy 15 (6), 329-332<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17643575251901514465" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ClCfbGk0d_YC" class="gsc_a_at">Discovery of a new family of bicyclic dideoxy nucleosides which inhibit HCMV by a non-nucleoside mechanism</a><div class="gs_gray">C McGuigan, RN Pathirana, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral research 57<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13849241440497460388" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:i2xiXl-TujoC" class="gsc_a_at">New bicyclic nucleoside analogues (BCNAs) show selective and specific activity against human cytomegalovirus (HCMV)</a><div class="gs_gray">G Andrei, J Balzarini, E De Clercq, R Pathirana, C McGuigan, R Snoeck</div><div class="gs_gray">Abstract book, 71<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4954470095012598759" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:S16KYo8Pm5AC" class="gsc_a_at">Bicyclic nucleoside inhibitors of varicella-zoster virus: The effect of branching in the p-alkylphenyl side-chain</a><div class="gs_gray">G Luoni, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral research, 53 53 (3), A59-A59<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4239863703388385967" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:r_AWSJRzSzQC" class="gsc_a_at">Design, Synthesis and Evaluation of Some Novel Nucleotides and Inhibitors of HIV</a><div class="gs_gray">C McGuigan, D Cahard, A Salgado, L Bidois, S Velazquez, CJ Yamold, ...</div><div class="gs_gray">SPECIAL PUBLICATION-ROYAL SOCIETY OF CHEMISTRY 198 (1), 251-258<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10998271115349790772" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:foquWX3nUaYC" class="gsc_a_at">Metabolism and anti-HIV activity of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety</a><div class="gs_gray">L Naesens, D Cahard, A Salgado, L Bidois, E De Clercq, C McGuigan, ...</div><div class="gs_gray">Clinical Biochemistry 3 (30), 271<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9398185332112812799" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:rmuvC79q63oC" class="gsc_a_at">The synthesis and biological evaluation of phosphate triester alkyl lysophospholipids (ALPs) as potential antineoplastic and anti-HIV agents</a><div class="gs_gray">Y Wang, C McGuigan, A Hay, N Mahmood, J Balzarini, E De Clercq, ...</div><div class="gs_gray">Antiviral Research 26 (3), A246-A246<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17902666208817569593" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PoWvk5oyLR8C" class="gsc_a_at">The reaction of dihydroxyacetone with ethanedithiol. Synthesis and x‐ray crystal structure of 1, 4, 7, 10‐tetrathiaspiro [5.5] undecane</a><div class="gs_gray">TA Hamor, AS Jones, RH Jones, C Mcguigan, RT Walker</div><div class="gs_gray">Journal of Heterocyclic Chemistry 20 (1), 33-35<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6754367413101057403" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:raTqNPD5sRQC" class="gsc_a_at">Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells <i>In Vitro</i></a><div class="gs_gray">M Slusarczyk, M Serpi, E Ghazaly, BM Kariuki, C McGuigan, C Pepper</div><div class="gs_gray">Journal of Medicinal Chemistry<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:YsrPvlHIBpEC" class="gsc_a_at">Phosphoramidate nucleoside derivatives as anticancer agents</a><div class="gs_gray">H Griffith, M Serpi, M Slusarczyk, C McGuigan</div><div class="gs_gray">US Patent App. 17/142,936<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:DBa1UEJaJKAC" class="gsc_a_at">Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, J Balzarini, M Slusarczyk, B Gonczy, P Murziani</div><div class="gs_gray">US Patent 10,993,957<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:mUJArPsKIAAC" class="gsc_a_at">Cancer treatments based on gemcitabine prodrugs</a><div class="gs_gray">H Griffith, C McGuigan, C Pepper</div><div class="gs_gray">US Patent App. 17/028,314<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:-nhnvRiOwuoC" class="gsc_a_at">Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancer</a><div class="gs_gray">SB Kandil, BM Kariuki, C McGuigan, AD Westwell</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry Letters 36, 127817<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:oi2SiIJ9l4AC" class="gsc_a_at">Phosphoramidate nucleoside derivatives as anticancer agents</a><div class="gs_gray">H Griffith, M Serpi, M Slusarczyk, C McGuigan</div><div class="gs_gray">US Patent 10,906,929<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:rbm3iO8VlycC" class="gsc_a_at">compostos derivados de fosforamidato, seus usos, composições farmacêuticas que os compreendem, métodos de preparação das referidas composições e processo para preparação de um&nbsp;…</a><div class="gs_gray">K Mills, C Congiatu, C McGuigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:w0F2JDEymm0C" class="gsc_a_at">Gemcitabine prodrugs</a><div class="gs_gray">H Griffith, C McGuigan, M Slusarczyk, M Serpi, V Ferrari</div><div class="gs_gray">US Patent App. 16/865,527<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:FiDNX6EVdGUC" class="gsc_a_at">Phosphorodiamidates and other phosphorus derivatives of fingolimod and related s1 p receptor modulators</a><div class="gs_gray">E Lloyd-Evans, F Pertusati, E James, E Maguire, C McGuigan</div><div class="gs_gray">US Patent App. 16/651,058<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:pAkWuXOU-OoC" class="gsc_a_at">2'and/or 5'amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds</a><div class="gs_gray">H Griffith, C McGuigan, V Ferrari, M Serpi, CJ Antunez</div><div class="gs_gray">US Patent App. 16/782,952<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:4X0JR2_MtJMC" class="gsc_a_at">2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds</a><div class="gs_gray">H Griffith, C McGuigan, V Ferrari, M Serpi, CJ Antunez</div><div class="gs_gray">US Patent 10,570,168<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:QyXJ3EUuO1IC" class="gsc_a_at">Abstract P5-05-06: Umbelliferon derivatives for androgen receptor positive triple negative breast cancer</a><div class="gs_gray">S Bhattacharya, P Westmark, N Siegel, Y Cai, S Kandil, AD Westwell, ...</div><div class="gs_gray">Cancer Research 80 (4 Supplement), P5-05-06-P5-05-06<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:-7ulzOJl1JYC" class="gsc_a_at">Adenosine derivatives for use in the treatment of cancer</a><div class="gs_gray">H Griffith, M Serpi, M Slusarczyk, C McGuigan</div><div class="gs_gray">US Patent App. 16/305,159<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:An6A6Jpfc1oC" class="gsc_a_at">Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer</a><div class="gs_gray">C Mcguigan, J Balzarini, M SLUSARCYZK, B GONCZY, P MURZIANI</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:EPG8bYD4jVwC" class="gsc_a_at">Compuestos químicos</a><div class="gs_gray">C Mcguigan, J Balzarini, M SLUSARCYZK, B GONCZY, P MURZIANI</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:pS0ncopqnHgC" class="gsc_a_at">Fosforoamidatni derivati 5-fluoro-2'-dezoksiuridina za upotrebu u tretmanu kancera</a><div class="gs_gray">C Mcguigan, J Balzarini, M Slusarcyzk, B Gonczy, P Murziani</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:LdasjJ6CEcoC" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C McGuigan, J Balzarini</div><div class="gs_gray">US Patent App. 15/141,992<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:48xauSegjOkC" class="gsc_a_at">In silico design and synthesis of novel thiourea and phenylsulfonyl-benzamide compounds as anti-prostate cancer agents</a><div class="gs_gray">M Bassetto, S Ferla, A Brancale, C McGuigan</div><div class="gs_gray">ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:DrR-2ekChdkC" class="gsc_a_at">Derivati fosforammidati di 5-fluoro-2'-desossiuridina per uso nel trattamento del cancro</a><div class="gs_gray">C Mcguigan, M Slusarcyzk, B Gonczy, P Murziani, J Balzarini</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HeT0ZceujKMC" class="gsc_a_at">PROTIDES AS A NEW ANTI-CANCER DRUG FAMILY</a><div class="gs_gray">C McGuigan, M Serpi, M Slusarczyk, V Ferrari, C Jimenez-Antunez</div><div class="gs_gray">ANTICANCER RESEARCH 35 (7), 4312-4312<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:eO3_k5sD8BwC" class="gsc_a_at">'-用於治療癌症的-氟-'-脱氧尿苷的氨基磷酸酯衍生物</a><div class="gs_gray">C Mcguigan, J Balzarini, M Slusarcyzk, B Gonczy, P Murziani</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kF1pexMAQbMC" class="gsc_a_at">Compuestos derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina; procedimiento de preparacion; composicion farmaceutica que los comprende; su uso en el tratamiento o&nbsp;…</a><div class="gs_gray">C Mcguigan, J Balzarini, M Slusarcyzk, B Gonczy, P Murziani</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:69ZgNCALVd0C" class="gsc_a_at">Phosphoramidate History of Nucleoside Compounds</a><div class="gs_gray">C Mcguigan, K Mills, C Congiatu</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:lgwcVrK6X84C" class="gsc_a_at">PRECLINICAL CHARACTERIZATION OF A SERIES OF HIGHLY POTENT PHOPHORODIAMIDATE NUCLEOTIDE ANALOGUE INHIBITORS OF HEPATITIS C POLYMERASE: 355</a><div class="gs_gray">J Vernachio, B Bleiman, D Bryant, S Chamberlain, B Ganguly, E Gorovits, ...</div><div class="gs_gray">Hepatology 54 (4)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:mWEH9CqjF64C" class="gsc_a_at">composto método de sintetizar um composto, uso de um composto, método de profilaxia ou tratamento de infecção viral, e, composição farmacêutica</a><div class="gs_gray">C Mcguigan, J Balzarini, M Migliore</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:wvYxNZNCP7wC" class="gsc_a_at">Antivirale pyrimidinnukleosidderivater, antivirale pyrimidinnukleosidderivater</a><div class="gs_gray">C Mcguigan, J Balzarini, M Migliore</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:9ZlFYXVOiuMC" class="gsc_a_at">Editorial Policy The overriding criteria for publication are originality, high scientific quality, adequate documentation by experimental evidence and relevance to the aims and&nbsp;…</a><div class="gs_gray">G Andrei, M Baba, F Baldanti, J Balzarini, AS Galabov, Q Ge, G Gosselin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kzcSZmkxUKAC" class="gsc_a_at">Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer</a><div class="gs_gray">C Mcguigan, K Mills, C Congiatu</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:SnGPuo6Feq8C" class="gsc_a_at">Pochodne fosforanowe (1R, cis)-4-(6-amino-9H-puryn-9-ylo)-2-cyklopenteno-1-metanolu, kompozycje zawierające te związki, sposób wytwarzania tych związków oraz ich zastosowanie</a><div class="gs_gray">SM Daluge, C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:OP4eGU-M3BUC" class="gsc_a_at">Application of the Protide Strategy to Some Novel Nucleoside Analogues</a><div class="gs_gray">AH Abdallah, C McGuigan</div><div class="gs_gray">Journal Of Agrobiotechnology 1, 43-58<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:v1_lew4L6wgC" class="gsc_a_at">Design, Synthesis, and Biological Evaluation of Novel Fluoro Derivatives of BCNA</a><div class="gs_gray">M Derudas, M Quintiliani, C McGuigan, A Brancale, G Henson, J Balzarini</div><div class="gs_gray">Antiviral Research 82 (2), A57<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:mNrWkgRL2YcC" class="gsc_a_at">An investigation into the anti-HIV activity of 2prime, 3prime-didehydro-2prime, 3prime-dideoxyuridine (d4U) and 2prime, 3prime-dideoxyuridine (ddU) phosphoramidateProTide&nbsp;…</a><div class="gs_gray">Y Mehellou, J Balzarini, C McGuigan</div><div class="gs_gray">ORGANIC AND BIOMOLECULAR CHEMISTRY 7 (12), 2548-2553<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:MpfHP-DdYjUC" class="gsc_a_at">Design, synthesis, and biological evaluation of novel anti-VZV agents</a><div class="gs_gray">M Derudas, C McGuigan, R Snoeck, G Andrei, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Research 74 (3), A72<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:1lhNe0rCu4AC" class="gsc_a_at">The design, synthesis and Anti-HIV activity of a selected group of 2', 3'-didehydro-2', 3'-dideoxyguanosine (d4G) and 2', 3'-dideoxyguanosine (ddG)'ProTide'derivatives</a><div class="gs_gray">Y Mehellou, C McGuigan, J Balzarini</div><div class="gs_gray">Antiviral Research 74 (3)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:cWzG1nlazyYC" class="gsc_a_at">Design, synthesis, and anti-HIV activity of 2prime, 3prime-didehydro-2prime, 3prime-dideoxyuridine (d4U), 2prime, 3prime-dideoxyuridine (ddU) phosphoramidateProTide'derivatives</a><div class="gs_gray">Y Mehellou, C McGuigan, A Brancale, J Balzarini</div><div class="gs_gray">BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS 17 (13), 3666-3669<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:BzfGm06jWhQC" class="gsc_a_at">Design, Synthesis, and Biological Evaluation of Novel Nucleoside Phosphoramidates as Potential Anti-HCV Agents: 100</a><div class="gs_gray">P Perrone, S Rajyaguru, M Kelleher, G Luoni, F Daverio, S Mulready, ...</div><div class="gs_gray">Antiviral Research 70 (1)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:prdVHNxh-e8C" class="gsc_a_at">Some modifications to the bicyclic pyrimidines: a novel class of anti-viral nucleosides</a><div class="gs_gray">A Angell, C McGuigan, L Avanzi, LG Sevillano, R Snoeck, G Andrei, ...</div><div class="gs_gray">Antiviral research 70 (1), A66-A67<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:jL-93Qbq4QoC" class="gsc_a_at">Phosphoramidate prodrugs of the most potent and selective anti-VZV bicyclic pyrimidine nucleosides</a><div class="gs_gray">MD Migliore, C McGuigan, R Snoeck, G Andrei, J Balzarini, E De Clercq</div><div class="gs_gray">Antiviral research, 65 65 (3), A95-A95<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:JTqpx9DYBaYC" class="gsc_a_at">Pyrimidine nucleoside analogues, their use in treating viral infection and preparation process thereof</a><div class="gs_gray">C Mcguigan, J Balzarini, CE De</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:DkZNVXde3BIC" class="gsc_a_at">Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol useful as antiviral agents</a><div class="gs_gray">SM Daluge, C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PaBasH6fAo0C" class="gsc_a_at">Bicyclic anti-VZV nucleosides: Thieno analogues bearing alkylphenyl side chain result in a reduction in antiviral activity</a><div class="gs_gray">A Angell, L Sevillano, C McGuigan, R Snoeck, G Andrei, J Balzarini, ...</div><div class="gs_gray">Antiviral research, 62 62 (2), A64-A65<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kVjdVfd2voEC" class="gsc_a_at">Differing SARs and MOAs emerge for the highly potent anti-VZV, BCNAs, and their anti-HCMV dd analogues</a><div class="gs_gray">C McGuigan, O Bidet, A Carangio, G Luoni, G Andrei, R Snoeck, ...</div><div class="gs_gray">Antiviral research, 62 62 (2), A55-A55<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:rTD5ala9j4wC" class="gsc_a_at">Analogues de (1 R, CIS)-4-(6-amino-9H-purin-9-YL)-2-cyclopentène-1-methanol comme agents antiviraux.</a><div class="gs_gray">SM Daluge, C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Dem6FJhTUoYC" class="gsc_a_at">Synthesis and Biological Evaluation of Bicyclic Furano Pyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus: 99</a><div class="gs_gray">M Kelleher, O Bidet, A Carangio, C McGuigan, H Weldon, G Andrei, ...</div><div class="gs_gray">Antiviral Research 57 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:6bLC7aUMtPcC" class="gsc_a_at">Discovery of a new family of bicyclic dideoxy with significant antiviral activity nucleosides which inhibit HCMV by a non-nucleoside mechanism</a><div class="gs_gray">C McGuigan, RN Pathirana, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral Research 57 (3), A57-A57<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:43bX7VzcjpAC" class="gsc_a_at">Synthesis and biological evaluation of a new series of 5-alkylaryl nucleoside analogues showing anti-HCMV activity</a><div class="gs_gray">G Luoni, C McGuigan, G Andrei, R Snoeck, E De Clercq, J Balzarini</div><div class="gs_gray">Antiviral research, 57 57 (3), A69-A69<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:zCSUwVk65WsC" class="gsc_a_at">Bicyclic furo pyrimidine nucleosides with haloaryl side chains</a><div class="gs_gray">A Angell, C McGuigan, A Jukes, H Baruki, S Blewett, G Andrei, R Snoeck, ...</div><div class="gs_gray">Antiviral research, 57 57 (3), A62-A62<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:6ZxmRoH8BuwC" class="gsc_a_at">ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION-Stereoselective and Concentration-Dependent Polarized Epithelial Permeability of a Series of Phosphoramidate Triester&nbsp;…</a><div class="gs_gray">D Siccardi, LE Kandalaft, M Gumbleton, C McGuigan</div><div class="gs_gray">Journal of Pharmacology and Experimental Therapeutics 307 (3), 1112-1119<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HJSXoJQnj-YC" class="gsc_a_at">Composto, métodos para tratar uma infecção por vìrus em um ser humano e para tratar uma infecção pelo vìrus da hepatite b em um ser humano, composição farmacêutica, uso de um&nbsp;…</a><div class="gs_gray">SM Daluge, C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:bKqednn6t2AC" class="gsc_a_at">ACCELERATED COMMUNICATIONS-Specific Recognition of the Bicyclic Pyrimidine Nucleoside Analogs, a New Class of Highly Potent and Selective Inhibitors of Varicella-Zoster Virus&nbsp;…</a><div class="gs_gray">R Sienaert, L Naesens, A Brancale, ED Clercq, C McGuigan, J Balzarini</div><div class="gs_gray">Molecular Pharmacology 61 (2), 249-254<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:7PzlFSSx8tAC" class="gsc_a_at">Molecular Basis of Disease</a><div class="gs_gray">J Balzarini, C McGuigan, D Banerjee, P Mayer-Kuckuk, G Capiaux, ...</div><div class="gs_gray">Biochimica et Biophysica Acta 1587, 338-340<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Zph67rFs4hoC" class="gsc_a_at">Reverse transcriptase of HIV as a target for anti-HIV chemotherapy</a><div class="gs_gray">J Balzarini, MJ Camarasa, A Holý, A Karlsson, C McGuigan, CF Perno</div><div class="gs_gray">Drug plus international 1, 13-7<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:BrOSOlqYqPUC" class="gsc_a_at">Anti-viral pyrimidine nucleoside analogues</a><div class="gs_gray">C Mcguigan, J Balzarini</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:OTTXONDVkokC" class="gsc_a_at">Abe, M., see Kobayashi, T. 141 Abollino, O., see Sarzanini, C. 343 Acha, V.—, Ruysschaert, J.-M. and Goormaghtigh, E. Stacks of close to 100 phospholipid bilayers fully&nbsp;…</a><div class="gs_gray">K Adbo, CJ Allender, HS Andersson, KR Brain, O Ramstrom, C Ballatore, ...</div><div class="gs_gray">Analytica Chimica Acta 435, 393-396<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:SGW5VrABaM0C" class="gsc_a_at">Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents</a><div class="gs_gray">SM Daluge, C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:tH6gc1N1XXoC" class="gsc_a_at">NUCLEOSIDES-NUCLEOTIDES-III. PHOSPHORYLATED MOLECULES AND PRONUCLEOTIDES-An In Situ Pig Liver Esterase Assay as a Useful Predictive Tool for the Likely In Vitro Anti Viral&nbsp;…</a><div class="gs_gray">C Ballatore, C McGuigan, ED Clercq, J Balzarini</div><div class="gs_gray">Nucleosides and Nucleotides 18 (4), 967-970<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:fFSKOagxvKUC" class="gsc_a_at">Synthesis, Biological and Physical Evaluation Of Some Novel Glycolipid Analogues</a><div class="gs_gray">WP Blackaby, C McGuigan, GS Attard, N Mahmood, AJ Hay, J Balzarini, ...</div><div class="gs_gray">Antiviral Research 30 (1), A35-A35<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:-95Q15plzcUC" class="gsc_a_at">28 Kinase bypass: A new strategy for antl-HIV drug design</a><div class="gs_gray">C McGuigan, D Kinchington, MF Wang, SR Nicholls, C Nickson, S Galpin, ...</div><div class="gs_gray">Antiviral Research 20, 55<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:u-coK7KVo8oC" class="gsc_a_at">Preparation of phosphoglycerides by phosphoramidite chemistry</a><div class="gs_gray">C McGuigan, MS Anson, B Swords</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 2075-2078<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:KNjnJ3z-R6IC" class="gsc_a_at">Potent anti-HIV activity of some phosphate derivatives of AZT</a><div class="gs_gray">C McGuigan, TJ O'Connor, D Curley, KG Devine, DJ Jeffries, B Jones, ...</div><div class="gs_gray">Antiviral Research 15, 71<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:VN7nJs4JPk0C" class="gsc_a_at">Nucleoside analogues</a><div class="gs_gray">C Mcguigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:ZfRJV9d4-WMC" class="gsc_a_at">The synthesis by phosphoramidite methodology of novel phospholipids related to ethylenediamine</a><div class="gs_gray">MS Anson, C McGuigan</div><div class="gs_gray">Journal of the Chemical Society, Perkin Transactions 1, 715-720<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:artPoR2Yc-kC" class="gsc_a_at">The synthesis of novel phospholipids related to ethylenediamine</a><div class="gs_gray">MS Anson, C McGuigan</div><div class="gs_gray">Journal of the Chemical Society, Chemical Communications, 1275-1276<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:9c2xU6iGI7YC" class="gsc_a_at">Studies on the Chemistry of Some Nucleoside Phosphates, Phosphites and Phosphoramidates</a><div class="gs_gray">C McGuigan</div><div class="gs_gray">University of Birmingham<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:TlpoogIpr_IC" class="gsc_a_at">Maschine zum Handhaben von im Betriebszustand in den Kanälen eines Kernreaktors angeordneten Brennstoffelementen</a><div class="gs_gray">G Lemesle, R Martin, M Monteil, R Roche, P Rouge</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1965</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PkcyUWeTMh0C" class="gsc_a_at">Monophosphate prodrugs of 5-azacytidine–synthesis and biological evaluation</a><div class="gs_gray">LS Thomsen, P Browne+, C Congiatu+, C McGuigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:kWvqk_afx_IC" class="gsc_a_at">INTRACELLULAR DELIVERY OF ANTI-HIV NUCLEOTIDES</a><div class="gs_gray">C McGuigan, D Kinchington, MF Wang, SR Nicholls, C Nickson, S Galpin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:PyEswDtIyv0C" class="gsc_a_at">W12 0HS, UK</a><div class="gs_gray">M Slusarczyk, MH Lopez, J Balzarini, M Mason, WG Jiang, S Blagden, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:HGTzPopzzJcC" class="gsc_a_at">PMCID: PMC1933301.</a><div class="gs_gray">J Elliott, E Fromentin, R Shattock, P Anton, R Gorelick, J Balzarini, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:KaMxkj08jr0C" class="gsc_a_at">Erik De Clercq Earl R. Kern and Richard J. Whitley Associate Editor For Reviews</a><div class="gs_gray">M Bray, G Andrei, M Baba, J Balzarini, L Carrasco, AS Galabov, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:1Ye0OR6EYb4C" class="gsc_a_at">Earl R. Kern and Richard J. Whitley Associate Editor For Reviews</a><div class="gs_gray">M Bray, G Andrei, M Baba, J Balzarini, L Carrasco, AS Galabov, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:jFemdcug13IC" class="gsc_a_at">Mike Bray</a><div class="gs_gray">DL Barnard, J Esté, M Prichard, S Vasudevan, HL Yen, G Andrei, M Baba, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:6_hjMsCP8ZoC" class="gsc_a_at">Erik De Clercq</a><div class="gs_gray">DL Barnard, M Bray, J Esté, S Vasudevan, G Andrei, M Baba, F Baldanti, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:U4n9YNQMCAIC" class="gsc_a_at">Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer</a><div class="gs_gray">C McGuigan, K Mills, C Congiatu</div><div class="gs_gray">US Patent 8,173,619<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:otzGkya1bYkC" class="gsc_a_at">Medicinal a Chemistry puD5aCS. Org/jmC</a><div class="gs_gray">C McGuigan, K Hinsinger, L Farleigh, RN Pathirana, JJ Bugert</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:buQ7SEKw-1sC" class="gsc_a_at">Novel nucleoside phosphoramidates as inhibitors of HIV: Studies on the stereochemical requirements of the</a><div class="gs_gray">C McGuigan, A Salgado, C Yarnold, TY Harries, E De Clercq, J Balzarini</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:wMgC3FpKEyYC" class="gsc_a_at">Barts</a><div class="gs_gray">E Ghazaly, I Rizzuto, H Gabra, N Habib, R Leonard, H Wasan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:lvd772isFD0C" class="gsc_a_at">volume 17 Numbw 24 1989 Nucleic Acids Research</a><div class="gs_gray">C McGuigan, JM ShacHeton, SM ToUerfield, PA Riley</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:yqoGN6RLRZoC" class="gsc_a_at">Medicinal Chemistry of Phosphonate Prodrugs for Antiviral Therapy</a><div class="gs_gray">F Pertusati, M Serpi, C McGuigan</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:DJbcl8HfkQkC" class="gsc_a_at">Freeman, DJ, see Spruance, SL, 305 Freeman, J., see Kreis, W., 323 Furneri, PM, see Garozzo, A., 267</a><div class="gs_gray">E Buimovici-Klein, V Mohan, M Lange, E Fenamore, Y Inada, LZ Cooper, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:GtLg2Ama23sC" class="gsc_a_at">MOLECULAR</a><div class="gs_gray">R Sienaert, L Nae-sens, A Brancale, E De Clercq, C McGuigan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=uaahAI4m4mMC&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=uaahAI4m4mMC:Ri6SYOTghG4C" class="gsc_a_at">1Instituto de Quimica Medica (CSIC), Spain, 2Cardiff University, United Kingdom, 3Katholieke Universiteit Leuven, Belgium We have described1 an entirely novel enzyme-based&nbsp;…</a><div class="gs_gray">S Velazquez, A Diez-Torrubia, C McGuigan, J Balzarini, MJ Camarasa</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–363</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>